{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_0", "document_index": 31, "latency_s": 1.1913517999928445, "prompt_toks": 18102, "completion_toks": 64}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Tenamfetamine\n\nPubChem CID\n\n1614\n\nStructure\n\nTenamfetamine_small.png\n\nTenamfetamine_3D_Structure.png\n\nChemical Safety\n\nAcute Toxic\n\nIrritant\n\nLaboratory Chemical Safety Summary (LCSS) Datasheet\n\nMolecular Formula\n\nC10H13NO2\n\nSynonyms\n\nTenamfetamine\n\n3,4-methylenedioxyamphetamine\n\nMethylenedioxyamphetamine\n\n4764-17-4\n\n3,4-Methylenedioxy-amphetamine\n\nMolecular Weight\n\n179.22 g/mol\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nDates\n\nCreate:\n\n2005-03-25\n\nModify:\n\n2025-04-19\n\nDescription\n\n3,4-Methylenedioxyamphetamine is a member of benzodioxoles.\n\nTENAMFETAMINE is a small molecule drug with a maximum clinical trial phase of II.\n\nAn amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.\n\nContents\n\n1 Structures\n\n1.1 2D Structure\n\nChemical Structure Depiction\n\nTenamfetamine.png\n\n\n                    Context: \n                    This chunk provides a summarized overview of Tenamfetamine's chemical identity, including its PubChem CID, molecular formula, synonyms, structure images, safety classification, and description. It highlights key data relevant for chemical identification, pharmacological properties, and research status, serving as an introductory reference within the comprehensive chemical database.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_1", "document_index": 31, "latency_s": 1.3740827000001445, "prompt_toks": 18278, "completion_toks": 89}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Contents\n\n1 Structures\n\n1.1 2D Structure\n\nChemical Structure Depiction\n\nTenamfetamine.png\n\n1.2 3D Conformer\n\n2 Names and Identifiers\n\n2.1 Computed Descriptors\n\n2.1.1 IUPAC Name\n\n1-(1,3-benzodioxol-5-yl)propan-2-amine\n\nComputed by Lexichem TK 2.7.0 (PubChem release 2021.10.14)\n\n2.1.2 InChI\n\nInChI=1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3\n\nComputed by InChI 1.0.6 (PubChem release 2021.10.14)\n\n2.1.3 InChIKey\n\nNGBBVGZWCFBOGO-UHFFFAOYSA-N\n\nComputed by InChI 1.0.6 (PubChem release 2021.10.14)\n\n2.1.4 SMILES\n\nCC(CC1=CC2=C(C=C1)OCO2)N\n\nComputed by OEChem 2.3.0 (PubChem release 2024.12.12)\n\n2.2 Molecular Formula\n\nC10H13NO2\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\n2.3 Other Identifiers\n\n2.3.1 CAS\n\n4764-17-4\n\n2.3.2 Deprecated CAS\n\n51497-09-7\n\n2.3.3 European Community (EC) Number\n\n803-951-7\n\n2.3.4 UNII\n\nXJZ28FJ27W\n\n2.3.5 ChEBI ID\n\nCHEBI:166520\n\n2.3.6 ChEMBL ID\n\nCHEMBL6731\n\n2.3.7 DrugBank ID\n\nDB01509\n\n2.3.8 DSSTox Substance ID\n\nDTXSID40859958\n\n\n                    Context: \n                    This section provides detailed chemical identifiers, including IUPAC name, InChI, InChIKey, SMILES, molecular formula, and other registry numbers such as CAS, EC, UNII, ChEBI, ChEMBL, and DrugBank. It complements the full webpage’s comprehensive chemical data by offering precise molecular descriptors crucial for researcher search and cross-referencing within the overall chemical profile of Tenamfetamine.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_2", "document_index": 31, "latency_s": 5.486284899991006, "prompt_toks": 18249, "completion_toks": 91}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    803-951-7\n\n2.3.4 UNII\n\nXJZ28FJ27W\n\n2.3.5 ChEBI ID\n\nCHEBI:166520\n\n2.3.6 ChEMBL ID\n\nCHEMBL6731\n\n2.3.7 DrugBank ID\n\nDB01509\n\n2.3.8 DSSTox Substance ID\n\nDTXSID40859958\n\n2.3.9 HMDB ID\n\nHMDB0041931\n\n2.3.10 KEGG ID\n\nD12715\n\n2.3.11 Metabolomics Workbench ID\n\n49636\n\n2.3.12 NCI Thesaurus Code\n\nC80152\n\n2.3.13 Nikkaji Number\n\nJ1.191.661I\n\nJ1.191.662G\n\nJ40.084J\n\n2.3.14 Pharos Ligand ID\n\nW94AR2N82Q8D\n\n2.3.15 Wikidata\n\nQ223020\n\n2.3.16 Wikipedia\n\n3,4-Methylenedioxyamphetamine\n\n2.4 Synonyms\n\n2.4.1 MeSH Entry Terms\n\n3,4 Methylenedioxyamphetamine\n\n3,4-Methylenedioxyamphetamine\n\n2.4.2 Depositor-Supplied Synonyms\n\nTenamfetamine\n\n3,4-methylenedioxyamphetamine\n\nMethylenedioxyamphetamine\n\n4764-17-4\n\n3,4-Methylenedioxy-amphetamine\n\nTenamfetamine [INN]\n\nMDA (pharmaceutical)\n\nTenamfetamina\n\nTenamfetaminum\n\nTenamfetaminum [Latin]\n\nTenamfetamina [Spanish]\n\nmethylene dioxyamphetamine\n\n1-(1,3-benzodioxol-5-yl)propan-2-amine\n\n1,3-Benzodioxole-5-ethanamine, alpha-methyl-\n\nTenanfetamina\n\nEA-1299\n\nLove\n\nBRN 0150196\n\n\n                    Context: \n                    This section provides standardized identifiers, classifications, and synonyms for the compound 3,4-methylenedioxyamphetamine, including UNII, ChEBI, ChEMBL, DrugBank IDs, and chemical synonyms such as Tenamfetamine and MDA. It is essential for search filtering, cross-referencing, and linking chemical data within the comprehensive PubChem record. The details facilitate precise chemical identification across multiple biological and chemical databases.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_3", "document_index": 31, "latency_s": 1.149367699996219, "prompt_toks": 18248, "completion_toks": 65}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Tenamfetamina [Spanish]\n\nmethylene dioxyamphetamine\n\n1-(1,3-benzodioxol-5-yl)propan-2-amine\n\n1,3-Benzodioxole-5-ethanamine, alpha-methyl-\n\nTenanfetamina\n\nEA-1299\n\nLove\n\nBRN 0150196\n\nAI3-24882\n\nalpha-Methyl-1,3-benzodioxole-5-ethanamine\n\nXJZ28FJ27W\n\nDEA No. 7400\n\nHSDB 7593\n\nALPHA-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE\n\nMDA (PSYCHEDELIC)\n\n5-19-08-00417 (Beilstein Handbook Reference)\n\nPhenethylamine, alpha-methyl-3,4-(methylenedioxy)-\n\nCHEMBL6731\n\nSKF-5\n\nTENAMFETAMINE [MART.]\n\nTENAMFETAMINE [WHO-DD]\n\n51497-09-7\n\n1,3-Benzodioxole-5-ethanamine, .alpha.-methyl-\n\n3,4-Methylenedioxyphenylisopropylamine\n\nTenamfetamine (INN)\n\nTenamfetaminum (Latin)\n\n(+/-)-3,4-(Methylenedioxy)amphetamine\n\nalpha-Methyl-3,4-methylenedioxyphenethylamine\n\n1-(2H-1,3-benzodioxol-5-yl)propan-2-amine\n\nTENAMFETAMINE (MART.)\n\n3,4-methylenedioxy-alpha-methyl-beta-phenylethylamine\n\nPhenethylamine, .alpha.-methyl-3,4-(methylenedioxy)-\n\n(+/-)-.ALPHA.-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE\n\n(-)-Tenamfetamine\n\n\n                    Context: \n                    This chunk provides alternative names, chemical identifiers, synonyms, and classification details for tenamfetamine, a psychoactive compound discussed in the full document. It includes chemical structure descriptions, regulatory codes, and related terminology that aid in indexing, search retrieval, and cross-referencing within the comprehensive chemical and pharmacological database.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_4", "document_index": 31, "latency_s": 1.1424655000009807, "prompt_toks": 18251, "completion_toks": 82}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    3,4-methylenedioxy-alpha-methyl-beta-phenylethylamine\n\nPhenethylamine, .alpha.-methyl-3,4-(methylenedioxy)-\n\n(+/-)-.ALPHA.-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE\n\n(-)-Tenamfetamine\n\nNCGC00168264-01\n\nMDA,R(-)\n\nUNII-XJZ28FJ27W\n\n3,4 Methylenedioxyamphetamine\n\n3-(1,3-benzodioxol-5-yl)-1,1,1,2,3-pentadeuteriopropan-2-amine\n\nMDA [MI]\n\nDivK1c_000964\n\nSCHEMBL393456\n\nMDA, (R,S)\n\nKBio1_000964\n\nDTXSID40859958\n\nCHEBI:166520\n\nNINDS_000964\n\nBDBM50005247\n\nPDSP1_001410\n\nPDSP2_001394\n\n(R,S)-3,4-Methylenedioxyamphetamine\n\n3,4-Methylenedioxyamphetamine (MDA)\n\n5-(2-Aminopropyl)-1,3-benzodioxole\n\nAKOS002433952\n\nDB01509\n\nIDI1_000964\n\nDB-290498\n\nDS-015925\n\n1-(3,4-Methylenedioxyphenyl)-2-propylamine\n\nNS00010421\n\n.alpha.-Methyl-3,4-methylenedioxyphenethylamine\n\n2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine\n\nD12715\n\nbenzene, 1-(2-amino)propyl-3,4-methylenedioxy-\n\n(-)2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine\n\n.alpha.-Methyl-3,4-(methylenedioxy)phenethylamine\n\n\n                    Context: \n                    This excerpt provides detailed identifiers, synonyms, and chemical names related to 3,4-methylenedioxy-alpha-methyl-beta-phenylethylamine (MDA), including chemical structure descriptions, database IDs, and alternative nomenclature. It enhances the comprehensive chemical and pharmacological data on MDA within the full PubChem profile, supporting precise search and retrieval of related chemical and biological information.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_5", "document_index": 31, "latency_s": 1.1981532000063453, "prompt_toks": 18228, "completion_toks": 84}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine\n\nD12715\n\nbenzene, 1-(2-amino)propyl-3,4-methylenedioxy-\n\n(-)2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine\n\n.alpha.-Methyl-3,4-(methylenedioxy)phenethylamine\n\n3,4-(Methylenedioxy)-alpha-methylphenylethylamine\n\nQ223020\n\n(+/-)2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine\n\n1,3-Benzodioxole-5-ethanamine, alpha-methyl- (9CI)\n\nDL-alpha-Methyl-3,4-(methylenedioxy)phenylethylamine\n\n(R)-(-)-2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine\n\n(S)-(+)-2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine\n\n1,3-Benzodioxole,5-ethanamine-.alpha.-methyl-(.+/-.)\n\n(+/-)-ALPHA-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE\n\n2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine((R)-(-)-MDA)\n\nrac-MDA (rac-3,4-Methylenedioxyamphetamine) 1.0 mg/ml in Methanol\n\n3 Chemical and Physical Properties\n\n3.1 Computed Properties\n\nProperty Name\n\nProperty Value\n\nReference\n\nProperty Name\n\nMolecular Weight\n\nProperty Value\n\n179.22 g/mol\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\n\n                    Context: \n                    This section lists various chemical synonyms, identifiers, and structural descriptors for the compound 2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine, including references, stereoisomers, and molecular weight data. It provides detailed chemical nomenclature and alternative names associated with the compound, situating it within the broader chemical and pharmacological database content of the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_6", "document_index": 31, "latency_s": 1.15466749999905, "prompt_toks": 18114, "completion_toks": 75}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    3.1 Computed Properties\n\nProperty Name\n\nProperty Value\n\nReference\n\nProperty Name\n\nMolecular Weight\n\nProperty Value\n\n179.22 g/mol\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nXLogP3\n\nProperty Value\n\n1.6\n\nReference\n\nComputed by XLogP3 3.0 (PubChem release 2021.10.14)\n\nProperty Name\n\nHydrogen Bond Donor Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nHydrogen Bond Acceptor Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nRotatable Bond Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nExact Mass\n\nProperty Value\n\n179.094628657 Da\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nMonoisotopic Mass\n\nProperty Value\n\n179.094628657 Da\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nTopological Polar Surface Area\n\n\n                    Context: \n                    This chunk presents the computed chemical properties of Tenamfetamine, including molecular weight, XLogP3, hydrogen bond donor and acceptor counts, rotatable bonds, exact mass, monoisotopic mass, and topological polar surface area, which are essential for understanding its physicochemical profile and are located within the full document's section on detailed chemical data.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_7", "document_index": 31, "latency_s": 1.49337490000471, "prompt_toks": 18069, "completion_toks": 67}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Property Name\n\nMonoisotopic Mass\n\nProperty Value\n\n179.094628657 Da\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nTopological Polar Surface Area\n\nProperty Value\n\n44.5 Å²\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nHeavy Atom Count\n\nProperty Value\n\n13\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nFormal Charge\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nComplexity\n\nProperty Value\n\n174\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nIsotope Atom Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nDefined Atom Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nUndefined Atom Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nDefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nUndefined Bond Stereocenter Count\n\nProperty Value\n\n\n                    Context: \n                    This chunk provides detailed physical and structural properties of Tenamfetamine, including monoisotopic mass, topological polar surface area, heavy atom count, formal charge, and molecular complexity. These computed chemical descriptors are part of the comprehensive chemical data on the webpage, supporting search and identification of the compound for scientific research and analysis.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_8", "document_index": 31, "latency_s": 1.0363003999955254, "prompt_toks": 18099, "completion_toks": 83}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Reference\n\nComputed by PubChem\n\nProperty Name\n\nDefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nUndefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nCovalently-Bonded Unit Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nCompound Is Canonicalized\n\nProperty Value\n\nYes\n\nReference\n\nComputed by PubChem (release 2021.10.14)\n\n3.2 Experimental Properties\n\n3.2.1 Color / Form\n\nAlmost colorless oil\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 995\n\n3.2.2 Boiling Point\n\n157 °C at 22 mm Hg; 80-90 °C at 0.2 mm Hg\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 995\n\n3.2.3 LogP\n\n1.64\n\nHANSCH,C & LEO,AJ (1985)\n\nlog Kow = 1.64\n\n\n                    Context: \n                    This excerpt provides key experimental physical and chemical property data for tenamfetamine, including its color, boiling point, and logP, as well as several computed molecular properties. Situated within the detailed chemical and physical characteristics section, it supports accurate identification and analysis of the compound for research and forensic purposes. These data enhance search relevance for properties, spectral data, and compound classification in the comprehensive PubChem profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_9", "document_index": 31, "latency_s": 1.1901878000062425, "prompt_toks": 18154, "completion_toks": 94}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    3.2.3 LogP\n\n1.64\n\nHANSCH,C & LEO,AJ (1985)\n\nlog Kow = 1.64\n\nHansch,C, Leo,AJ; Medchem Project. Issue no. 26. Claremont, CA: Pomona College (1985)\n\n1.64\n\n3.2.4 Decomposition\n\nWhen heated to decomposition it emits toxic fumes of /Nitrogen oxides/.\n\nLewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2438\n\n3.2.5 Dissociation Constants\n\npKa\n\n9.67 (at 25 °C)\n\nPERRIN,DD (1965)\n\npKa = 9.67 (conjugate acid)\n\nPerrin DD; Dissociation constants of organic bases in aqueous solution. IUPAC Chem Data Ser, Buttersworth, London (1965)\n\n3.2.6 Kovats Retention Index\n\nStandard non-polar\n\n1443 , 1443 , 1434 , 1470 , 1495 , 1472 , 1480 , 1464.6 , 1472 , 1460 , 1460\n\nSemi-standard non-polar\n\n1508.8 , 1484 , 1483 , 1496.3 , 1469.2 , 1457.4\n\nStandard polar\n\n2204 , 2204\n\n3.2.7 Other Experimental Properties\n\n\n                    Context: \n                    This chunk details key physical and chemical properties of Tenamfetamine, including its LogP (1.64), decomposition fumes (nitrogen oxides), dissociation constant (pKa 9.67), Kovats retention index values, and other experimental data. Positioned within the broader chemical profile, these parameters are essential for understanding its molecular behavior, analytical characterization, and safety considerations. The information supports research, analytical detection, and risk assessment of this compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_10", "document_index": 31, "latency_s": 1.1747139999934006, "prompt_toks": 18119, "completion_toks": 84}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Semi-standard non-polar\n\n1508.8 , 1484 , 1483 , 1496.3 , 1469.2 , 1457.4\n\nStandard polar\n\n2204 , 2204\n\n3.2.7 Other Experimental Properties\n\nCrystals from isopropanol/ether, mp 187-188 °C ... also reported as mp 180-181 °C ... Easily soluble in water, alcohol /Hydrochloride/\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 995\n\n3.3 Chemical Classes\n\nStimulant\n\nS120 | DUSTCT2024 | Substances from Second NORMAN Collaborative Dust Trial | DOI:10.5281/zenodo.13835254\n\n3.3.1 Drugs\n\nPharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds\n\nS58 | PSYCHOCANNAB | Synthetic Cannabinoids and Psychoactive Compounds | DOI:10.5281/zenodo.3247723\n\nPharmaceuticals -> Illicit drugs\n\nS56 | UOATARGPHARMA | Target Pharmaceutical/Drug List from University of Athens | DOI:10.5281/zenodo.3248837\n\n3.3.1.1 Human Drugs\n\nPharmaceuticals\n\n\n                    Context: \n                    This chunk provides specific experimental data on the physical and chemical properties of Tenamfetamine, including polar and non-polar retention indices, solubility, melting point, and classification as a stimulant drug within pharmaceutical and illicit drug categories. It complements the comprehensive chemical, pharmacological, and safety information in the full pubchem record, aiding precise retrieval of physicochemical and classification details related to this compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_11", "document_index": 31, "latency_s": 1.0639976999955252, "prompt_toks": 18125, "completion_toks": 72}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Pharmaceuticals -> Illicit drugs\n\nS56 | UOATARGPHARMA | Target Pharmaceutical/Drug List from University of Athens | DOI:10.5281/zenodo.3248837\n\n3.3.1.1 Human Drugs\n\nPharmaceuticals\n\nS72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664\n\n4 Spectral Information\n\n4.1 1D NMR Spectra\n\n4.1.1 1H NMR Spectra\n\nInstrument Name\n\nVarian A-60\n\nSource of Sample\n\nAldrich Chemical Company, Inc., Milwaukee, Wisconsin\n\nCopyright\n\nCopyright © 2009-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.1.2 13C NMR Spectra\n\nCopyright\n\nCopyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.2 Mass Spectrometry\n\n4.2.1 GC-MS\n\n1 of 8\n\nView All\n\nNIST Number\n\n352965\n\nLibrary\n\nMain library\n\nTotal Peaks\n\n94\n\nm/z Top Peak\n\n44\n\nm/z 2nd Highest\n\n136\n\nm/z 3rd Highest\n\n135\n\nThumbnail\n\nThumbnail\n\n2 of 8\n\nView All\n\nNIST Number\n\n386207\n\nLibrary\n\nMain library\n\nTotal Peaks\n\n79\n\n\n                    Context: \n                    This section presents spectral data and analytical information related to spectral analysis methods, including NMR and mass spectrometry, for compounds classified under illicit drugs and pharmaceutical substances. It provides instrument details, sample sources, and key spectral parameters such as NIST library numbers and peaks, supporting chemical identification and forensic analysis within the broader chemical and toxicological context of the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_12", "document_index": 31, "latency_s": 1.3594129999983124, "prompt_toks": 18213, "completion_toks": 73}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Main library\n\nTotal Peaks\n\n94\n\nm/z Top Peak\n\n44\n\nm/z 2nd Highest\n\n136\n\nm/z 3rd Highest\n\n135\n\nThumbnail\n\nThumbnail\n\n2 of 8\n\nView All\n\nNIST Number\n\n386207\n\nLibrary\n\nMain library\n\nTotal Peaks\n\n79\n\nm/z Top Peak\n\n44\n\nm/z 2nd Highest\n\n136\n\nm/z 3rd Highest\n\n135\n\nThumbnail\n\nThumbnail\n\n4.2.2 MS-MS\n\n1 of 9\n\nView All\n\nSpectra ID\n\n2238500\n\nIonization Mode\n\nPositive\n\nSPLASH\n\nsplash10-0fba-9200000000-e71b359c869f7c1b90b3\n\nTop 5 Peaks\n\n77.0384 100\n\n95.049 99.84\n\n105.0446 67.95\n\n79.0541 63.18\n\n51.0229 57.64\n\nThumbnail\n\nThumbnail\n\n2 of 9\n\nView All\n\nSpectra ID\n\n2239063\n\nIonization Mode\n\nPositive\n\nSPLASH\n\nsplash10-0fb9-9500000000-b52b9c038a0be1fb60fb\n\nTop 5 Peaks\n\n79.0541 100\n\n77.0384 70.25\n\n95.049 69.43\n\n103.0541 58.47\n\n105.0446 46.25\n\nThumbnail\n\nThumbnail\n\n4.2.3 LC-MS\n\n1 of 35\n\nView All\n\nAccession ID\n\nMSBNK-BAFG-CSL23111018581\n\nAuthors\n\nKevin S. Jewell; Björn Ehlig; Arne Wick\n\nInstrument\n\nTripleTOF 6600 SCIEX\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\n\n                    Context: \n                    This excerpt details the mass spectrometry data associated with the compound, including spectral peaks from NIST library matches, MS/MS spectra identifiers, ionization modes, and instrument details from LC-MS analyses. It provides critical analytical parameters for compound identification and verification, essential for researchers performing chemical detection or forensic analysis within the comprehensive chemical profile presented in the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_13", "document_index": 31, "latency_s": 1.1955334000085713, "prompt_toks": 18180, "completion_toks": 106}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    MSBNK-BAFG-CSL23111018581\n\nAuthors\n\nKevin S. Jewell; Björn Ehlig; Arne Wick\n\nInstrument\n\nTripleTOF 6600 SCIEX\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\nCollision Energy\n\n110\n\nFragmentation Mode\n\nCID\n\nColumn Name\n\nZorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent\n\nRetention Time\n\n5.295 min\n\nPrecursor m/z\n\n180.1019\n\nPrecursor Adduct\n\n[M+H]+\n\nTop 5 Peaks\n\n50.0148 999\n\n51.0219 792\n\n39.0228 284\n\n37.0075 280\n\n62.0152 235\n\nSPLASH\n\nsplash10-0udi-9000000000-bf76d1ace60049ee18cf\n\nThumbnail\n\nThumbnail\n\nLicense\n\ndl-de/by-2-0\n\n2 of 35\n\nView All\n\nAccession ID\n\nMSBNK-BAFG-CSL23111018582\n\nAuthors\n\nKevin S. Jewell; Björn Ehlig; Arne Wick\n\nInstrument\n\nTripleTOF 6600 SCIEX\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\nCollision Energy\n\n30\n\nFragmentation Mode\n\nCID\n\nColumn Name\n\nZorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent\n\nRetention Time\n\n5.295 min\n\nPrecursor m/z\n\n180.1019\n\nPrecursor Adduct\n\n\n                    Context: \n                    This excerpt details two LC-MS/MS analytical method entries for a compound analyzed with TripleTOF 6600 SCIEX instruments, including parameters such as authors, instrumentation, collision energies, retention times, precursor ions, and top fragment peaks. It is relevant to the comprehensive chemical identification, analytical methods, and spectral data provided in the full PubChem record for Tenamfetamine, supporting compound verification and reproducibility. The specific SPLASH identifiers, instrument details, and license information enhance search precision for related analytical datasets.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_14", "document_index": 31, "latency_s": 1.0542034999962198, "prompt_toks": 18156, "completion_toks": 75}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ESI\n\nCollision Energy\n\n30\n\nFragmentation Mode\n\nCID\n\nColumn Name\n\nZorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent\n\nRetention Time\n\n5.295 min\n\nPrecursor m/z\n\n180.1019\n\nPrecursor Adduct\n\n[M+H]+\n\nTop 5 Peaks\n\n105.0693 999\n\n135.0435 718\n\n133.0638 420\n\n79.0536 267\n\n77.0378 195\n\nSPLASH\n\nsplash10-0a4r-1900000000-c93dea273da06e219237\n\nThumbnail\n\nThumbnail\n\nLicense\n\ndl-de/by-2-0\n\n4.3 UV Spectra\n\n4.3.1 UV-VIS Spectra\n\nCopyright\n\nCopyright © 2008-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.4 IR Spectra\n\n4.4.1 FTIR Spectra\n\nTechnique\n\nCAPILLARY CELL: NEAT\n\nSource of Sample\n\nAldrich Chemical Company, Inc., Milwaukee, Wisconsin\n\nCopyright\n\nCopyright © 1980, 1981-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.4.2 ATR-IR Spectra\n\nInstrument Name\n\nBio-Rad FTS\n\nTechnique\n\nATR-Film (MeCl2) (DuraSamplIR II)\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nLipomed AG\n\nCatalog Number\n\nFree base of MDA-79-HC-1LM\n\n\n                    Context: \n                    This excerpt details analytical methods and spectral data for identifying tenamfetamine, including LC-MS parameters such as collision energy, retention time, precursor m/z, and top peaks, as well as UV and IR spectra sources and techniques. It is relevant for chemical identification and forensic analysis within the comprehensive PubChem entry, providing essential spectral reference information for laboratory detection and verification.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_15", "document_index": 31, "latency_s": 0.9972114999982296, "prompt_toks": 18069, "completion_toks": 80}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Instrument Name\n\nBio-Rad FTS\n\nTechnique\n\nATR-Film (MeCl2) (DuraSamplIR II)\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nLipomed AG\n\nCatalog Number\n\nFree base of MDA-79-HC-1LM\n\nLot Number\n\nFree base of 94.3B10.2L1\n\nCopyright\n\nCopyright © 2014-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.5 Raman Spectra\n\nCopyright\n\nCopyright © 2024-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n5 Related Records\n\n5.1 Related Compounds with Annotation\n\nFollow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see here for details), but these live search links provide equivalent functionality to the table that was previously shown here.\n\n5.2 Related Compounds\n\nSame Connectivity Count\n\n18\n\nSame Stereo Count\n\n15\n\nSame Isotope Count\n\nSame Parent, Connectivity Count\n\n31\n\nSame Parent, Stereo Count\n\n24\n\nSame Parent, Isotope Count\n\n13\n\n\n                    Context: \n                    This segment details the Raman spectra acquisition for the compound, including instrument specifications, sample source, and catalog information. It situates within the \"4 Spectral Information\" section of the webpage, highlighting analytical methods and spectrum provenance. Additionally, it connects to the \"5 Related Records\" section, providing data on related compounds' connectivity, stereo, and isotope counts relevant for chemical similarity searches.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_16", "document_index": 31, "latency_s": 1.2193399999960093, "prompt_toks": 18089, "completion_toks": 91}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    5.2 Related Compounds\n\nSame Connectivity Count\n\n18\n\nSame Stereo Count\n\n15\n\nSame Isotope Count\n\nSame Parent, Connectivity Count\n\n31\n\nSame Parent, Stereo Count\n\n24\n\nSame Parent, Isotope Count\n\n13\n\nSame Parent, Exact Count\n\nMixtures, Components, and Neutralized Forms Count\n\n18\n\nSimilar Compounds (2D)\n\nView in PubChem Search\n\nSimilar Conformers (3D)\n\nView in PubChem Search\n\n5.3 Substances\n\n5.3.1 PubChem Reference Collection SID\n\n505887273\n\n5.3.2 Related Substances\n\nAll Count\n\n168\n\nSame Count\n\n84\n\nMixture Count\n\n84\n\n5.3.3 Substances by Category\n\n5.4 Entrez Crosslinks\n\nPubMed Count\n\n332\n\nTaxonomy Count\n\nGene Count\n\n16\n\n5.5 Associated Chemicals\n\n3,4-Methylenedioxyamphetamine hydrochloride; 6292-91-7\n\n5.6 NCBI LinkOut\n\n6 Chemical Vendors\n\n7 Drug and Medication Information\n\n7.1 Drug Transformations\n\n3,4-Methylenedioxyamphetamine is a known transformation product of 3,4-Methylenedioxy-N-ethylamphetamine and 3,4-Methylenedioxy-N-methylamphetamine.\n\n\n                    Context: \n                    This section details related chemical compounds and substances associated with tenamfetamine, including counts of structurally similar compounds (same connectivity, stereo, isotope, and parent forms), as well as information on related substances, category classifications, and crosslinks to PubMed and NCBI. It also notes known drug transformations, highlighting the biochemical relationships between tenamfetamine and its precursor or derivative molecules, which are crucial for chemical pharmacology and toxicity analyses.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_17", "document_index": 31, "latency_s": 1.1594381000031717, "prompt_toks": 17990, "completion_toks": 76}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    7.1 Drug Transformations\n\n3,4-Methylenedioxyamphetamine is a known transformation product of 3,4-Methylenedioxy-N-ethylamphetamine and 3,4-Methylenedioxy-N-methylamphetamine.\n\nS66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448\n\n7.2 Clinical Trials\n\n7.2.1 ClinicalTrials.gov\n\n7.3 Therapeutic Uses\n\nAdrenergic Uptake Inhibitors; Hallucinogens; Serotonin Agents\n\nNational Library of Medicine's Medical Subject Headings online file (MeSH, 1999)\n\n8 Pharmacology and Biochemistry\n\n8.1 MeSH Pharmacological Classification\n\nAdrenergic Uptake Inhibitors\n\n\n                    Context: \n                    This excerpt covers drug transformation pathways, clinical trial resources, and therapeutic classifications related to 3,4-methylenedioxyamphetamine, a key psychoactive compound. It details its metabolic origins from related substances and lists its potential medical uses, such as adrenergic uptake inhibition and hallucinogenic effects, providing essential pharmacological and research context within the full chemical profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_18", "document_index": 31, "latency_s": 1.2509047000057762, "prompt_toks": 17961, "completion_toks": 70}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)\n\n8 Pharmacology and Biochemistry\n\n8.1 MeSH Pharmacological Classification\n\nAdrenergic Uptake Inhibitors\n\nDrugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)\n\nHallucinogens\n\n\n                    Context: \n                    This segment provides classifications of pharmacological drug categories from the MeSH database, specifically detailing adrenergic uptake inhibitors and hallucinogens. It situates within the broader pharmacology and biochemistry section, highlighting relevant drug classes related to the chemical's effects and mechanisms, and enhances searchability for drug action, classification, and related pharmacological data.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_19", "document_index": 31, "latency_s": 1.0179407999967225, "prompt_toks": 17951, "completion_toks": 73}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Hallucinogens\n\nDrugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)\n\nSerotonin Agents\n\nDrugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons. (See all compounds classified as Serotonin Agents.)\n\n8.2 Absorption, Distribution and Excretion\n\n\n                    Context: \n                    This section provides detailed definitions and classifications of hallucinogens and serotonin agents, key pharmacological categories discussed in the full document. It also includes information on the absorption, distribution, and excretion processes relevant to these drug classes. This contextualizes chemical, behavioral, and toxicological data on compounds like tenamfetamine, highlighting their neuropharmacological effects.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_20", "document_index": 31, "latency_s": 1.2872695999976713, "prompt_toks": 18061, "completion_toks": 71}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ... This paper describes for the first time an evaluation of the concentrations of methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) found in five fatalities admitted to hospital where both antemortem and postmortem blood samples were available. Admission MDMA and MDA concentrations ranged between 0.55 and 4.33 mg/L and 0 and 0.10 mg/L, respectively, in antemortem serum/plasma. Postmortem blood MDMA and MDA concentrations ranged between 0.47 and 28.39 mg/L and 0.02 and 1.33 mg/L, respectively. Postmortem concentrations were higher than corresponding antemortem concentrations in all 5 cases with postmortem/antemortem ratios between 1.1 and 6.6 for MDMA and 1.5 and 13.3 for MDA. Differences in concentrations were also observed between anatomical sites, with central sites (e.g., heart) having much higher concentrations than peripheral sites (e.g., femoral). Overall, MDMA and MDA appear to exhibit postmortem redistribution and concentrations measured in\n\n\n                    Context: \n                    This excerpt summarizes forensic toxicology findings on the postmortem and antemortem blood concentrations of MDMA and MDA in fatalities, highlighting postmortem redistribution and site-dependent variations. It is relevant to sections on toxicity, metabolism, and analytical methods within the full chemical profile, providing critical data for understanding overdose cases and toxicokinetics of these substances.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_21", "document_index": 31, "latency_s": 1.4745762999955332, "prompt_toks": 17879, "completion_toks": 90}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    central sites (e.g., heart) having much higher concentrations than peripheral sites (e.g., femoral). Overall, MDMA and MDA appear to exhibit postmortem redistribution and concentrations measured in postmortem specimens (even from peripheral sites) are not directly comparable with antemortem findings close to or prior to death.\n\n\n                    Context: \n                    This excerpt discusses postmortem drug distribution patterns of MDMA and MDA, highlighting that central blood sites (e.g., heart) tend to have higher concentrations than peripheral sites (e.g., femoral), which affects interpretation of toxicology results. It emphasizes that postmortem measurements, even from peripheral locations, do not reliably reflect antemortem levels, underscoring the importance of understanding postmortem redistribution in forensic analysis of these substances.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_22", "document_index": 31, "latency_s": 1.3610234999941895, "prompt_toks": 18061, "completion_toks": 110}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:16105252\n\nElliott SP; J Anal Toxicol 29 (5): 296-300 (2005)\n\nData ... reported /here/ include postmortem distribution of methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) in heart blood, gastric content, urine, and bile specimens from 20 fatal cases; other drugs found in the heart blood from these 20 cases; and the distribution of MDMA and MDA in 25 antemortem urine and 6 hair specimens. The MDA/MDMA concentration ratio observed in a limited number of hair specimens (n=6) are consistent and appear to be higher than those found in other specimens. Compared to other commonly abused drugs (e.g., cocaine and heroin), the \"drug/metabolite\" concentration ratio (MDMA/MDA) in hair is not significantly different from the ratios derived from other specimens, such as urine and blood. This observation is consistent with the relative drug/metabolite incorporation rates reported for cocaine/benzoylecgonine, tetrahydrocannabinol/tetrahydrocannabinoic acid, and MDMA/MDA.\n\n\n                    Context: \n                    This excerpt summarizes a 2005 study by Elliott et al. on postmortem and antemortem distribution of MDMA and MDA in various biological specimens, highlighting data from 20 fatal cases, additional drugs detected, and drug ratios in hair, urine, and blood. It supports the document's comprehensive coverage of analytical and toxicological data for these compounds, emphasizing their forensic detection, distribution patterns, and incorporation rates across biological matrices. Such information is relevant for understanding postmortem drug redistribution and forensic toxicology analysis of MDMA and MDA.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_23", "document_index": 31, "latency_s": 1.138007600005949, "prompt_toks": 17853, "completion_toks": 88}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:16105252\n\nLiu RH et al; J Anal Toxicol 30 (8): 545-50 (2006)\n\n8.3 Metabolism / Metabolites\n\n\n                    Context: \n                    This excerpt provides detailed information on the metabolism and metabolites of 3,4-methylenedioxyamphetamine (MDA), including pathways involved in drug biotransformation, enzymatic processes, and metabolite identification methods. It is relevant to the overall document's focus on chemical properties, biological activities, and toxicology of Tenamfetamine and its related compounds, aiding in understanding its pharmacokinetics and safety profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_24", "document_index": 31, "latency_s": 1.596817600002396, "prompt_toks": 18119, "completion_toks": 147}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    The phase I and II metabolites of the designer drugs methylenedioxyamphetamine (MDA), R,S-methylenedioxymethamphetamine (MDMA), R,S-methylenedioxyethylamphetamine (MDE), R, S-benzodioxazolylbutanamine (BDB) and R, S-N-methyl-benzodioxazolylbutanamine (MBDB) were identified by gas chromatography-mass spectrometry (GC-MS) or liquid chromotography-mass spectrometry (LC-MS) in urine and liver microsomes of humans and rats. Two overlapping pathways could be postulated: (1) demethylenation followed by catechol-O-methyl-transferase (COMT) catalyzed methylation and/or glucuronidation/sulfatation; (2) N-dealkylation, deamination and only for MDA, MDMA, MDE oxidation to the corresponding benzoic acid derivatives conjugated with glycine. Demethylenation was mainly catalyzed by CYP2D1/6 or CYP3A2/4, but also by CYP independent mechanisms. In humans, MDMA and MBDB could also be demethylenated by CYP1A2. N-demethylation was mainly catalyzed by CYP1A2, N-deethylation by CYP3A2/4. ...\n\nPMID:10720722\n\n\n                    Context: \n                    This section details the metabolic pathways and enzymatic processes involved in the phase I and II metabolism of designer drugs including MDA, MDMA, MDE, BDB, and MBDB, identified via GC-MS and LC-MS in human and rat urine and liver microsomes. It highlights key enzymatic mechanisms such as demethylenation, methylation, glucuronidation, sulfatation, N-dealkylation, and oxidation, with notable roles for CYP2D1/6, CYP3A2/4, and CYP1A2. This information is crucial for understanding their biotransformation, toxicity, and detection within the broader chemical and toxicological profile provided in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_25", "document_index": 31, "latency_s": 1.1530773999984376, "prompt_toks": 18046, "completion_toks": 98}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:10720722\n\nMaurer HH et al; Toxicol Lett 112-113: 133-42 (2000)\n\nThe two major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA), alpha-methyldopamine (alpha-MeDA) and 3-O-methyl-alpha-methyldopamine (3-O-Me-alpha-MeDA), were administered to rats intracerebroventricularly and into brain parenchyma. In addition, their precursors, (alpha-MeDOPA and 3-O-Me-alpha-MeDOPA, respectively) were administered systemically, individually and in combination. None of these treatments produced a lasting depletion of brain serotonin (5-HT). These findings suggest that neither of MDA's major metabolites mediate its toxic effects on 5-HT neurons and that either a minor metabolite is responsible or that alternate mechanisms are involved.\n\nPMID:1860050\n\nMcCann UD, Ricaurte GA; Brain Res 545 (1-2): 279-82 (1991)\n\n\n                    Context: \n                    This excerpt details research on the metabolites of MDA, specifically alpha-methyldopamine and 3-O-methyl-alpha-methyldopamine, and their lack of long-term neurotoxic effects on brain serotonin in rats. It is relevant to understanding the toxic mechanisms of MDA and its major metabolites, contrasting with broader chemical and toxicological information provided in the full document. These findings suggest that MDA's toxicity may involve other pathways or minor metabolites.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_26", "document_index": 31, "latency_s": 0.9243215000024065, "prompt_toks": 18064, "completion_toks": 81}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    3,4-Methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are ring-substituted amphetamine derivatives with stimulant and hallucinogenic properties. The recreational use of these amphetamines, especially MDMA, is prevalent despite warnings of irreversible damage to the central nervous system. MDA and MDMA are primarily serotonergic neurotoxicants. Because (1) neither MDA nor MDMA produces neurotoxicity when injected directly into brain, (2) intracerebroventricular (i.c.v.) administration of some major metabolites of MDA and MDMA fails to reproduce their neurotoxicity, (3) alpha-methyldopamine (alpha-MeDA) and N-methyl-alpha-MeDA are metabolites of both MDA and MDMA, (4) alpha-MeDA and N-methyl-alpha-MeDA are readily oxidized to the corresponding ortho-quinones, which can undergo conjugation with glutathione (GSH), and (5) quinone thioethers exhibit a variety of toxicologic activities, /the investigators/ initiated studies on the potential role of\n\n\n                    Context: \n                    This excerpt summarizes the neurotoxic properties and metabolic mechanisms of the psychoactive compounds MDA and MDMA, highlighting their stimulant and hallucinogenic effects, prevalence of recreational use, and their metabolism into neurotoxic quinone derivatives. It provides context for understanding their neurotoxicity and toxic metabolites, complementing the detailed chemical, pharmacological, and toxicity data found throughout the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_27", "document_index": 31, "latency_s": 1.1054271000029985, "prompt_toks": 18008, "completion_toks": 87}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    which can undergo conjugation with glutathione (GSH), and (5) quinone thioethers exhibit a variety of toxicologic activities, /the investigators/ initiated studies on the potential role of thioether metabolites of alpha-MeDA and N-methyl-alpha-MeDA in the neurotoxicity of MDA and MDMA. /These/ studies have revealed that the thioether conjugates stimulate the acute release of serotonin, dopamine, and norepinephrine and produce a behavioral response commensurate with the \"serotonin syndrome.\" Direct injection of the conjugates into rat brain also produces long-term depletions in serotonin (5-HT) concentrations, elevations in GFAP expression, and activation of microglial cells. The data are consistent with the view that thioether metabolites of alpha-MeDA and N-methyl-alpha-MeDA contribute to the neurotoxicity of the parent amphetamines.\n\n\n                    Context: \n                    This section discusses the toxicological mechanisms of alpha-MeDA and N-methyl-alpha-MeDA metabolites of MDA and MDMA, highlighting their role in neurotoxicity. It details how thioether conjugates stimulate neurotransmitter release, induce behavioral effects like serotonin syndrome, and cause long-term serotonergic depletion and microglial activation in rat brains, emphasizing their contribution to the parent drugs' neurotoxic effects.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_28", "document_index": 31, "latency_s": 1.15591129999666, "prompt_toks": 17842, "completion_toks": 72}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:15228153\n\nMomks TJ et al; Ther Drug Monit 26 (2): 132-6 (2004)\n\n\n                    Context: \n                    This chunk reports on the postmortem distribution and concentration ratios of MDMA and MDA in various biological specimens from fatalities, providing detailed toxicological data. It is relevant to the document’s comprehensive coverage of the pharmacology, toxicity, and analytical methods related to tenamfetamine and its related compounds, supporting understanding of their toxicokinetics and forensic identification.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_29", "document_index": 31, "latency_s": 1.0122136999998474, "prompt_toks": 18120, "completion_toks": 110}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    3,4-Methylenedioxyamphetamine (MDA) and 3,4-methyl-enedioxymethamphetamine (MDMA, ecstasy) are widely abused amphetamine derivatives that target the serotonin system. The serotonergic neurotoxicity of MDA and MDMA seems dependent on their systemic metabolism. 5-(Glutathion-S-yl)-alpha-methyldopamine [5-(GSyl)-alpha-MeDA] and 2,5-bis(glutathion-S-yl)-alpha-methyldopamine [2,5-bis(GSyl)-alpha-MeDA], metabolites of MDA and MDMA, are also selective serotonergic neurotoxicants and produce behavioral and neurochemical changes similar to those seen with MDA and MDMA. 5-(GSyl)-alpha-MeDA and 2,5-bis(GSyl)-alpha-MeDA are more potent than MDA and MDMA (K(i) = 69, 50, 107, and 102 microM, respectively) at inhibiting 5-hy-droxytryptamine (serotonin) transport into SK-N-MC cells transiently transfected with the human serotonin transporter (hSERT). Moreover, 5-(GSyl)-alpha-MeDA and 2,5-bis(GSyl)-alpha-MeDA simultaneously stimulated dopamine (DA) transport into the hSERT-expressing cells, an effect\n\n\n                    Context: \n                    This excerpt details the neurotoxic mechanisms of MDA and MDMA, focusing on their metabolism-derived metabolites 5-(GSyl)-alpha-MeDA and 2,5-bis(GSyl)-alpha-MeDA, which inhibit serotonin transport and stimulate dopamine transport via the serotonin transporter, contributing to their serotonergic neurotoxicity. It is relevant within the document's comprehensive analysis of the chemical's toxicology, metabolism, and neuropharmacology, highlighting key metabolites that affect serotonergic and dopaminergic systems.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_30", "document_index": 31, "latency_s": 1.090674000006402, "prompt_toks": 18028, "completion_toks": 81}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    with the human serotonin transporter (hSERT). Moreover, 5-(GSyl)-alpha-MeDA and 2,5-bis(GSyl)-alpha-MeDA simultaneously stimulated dopamine (DA) transport into the hSERT-expressing cells, an effect attenuated by fluoxetine, indicating that stimulated DA transport was hSERT-dependent. Finally, 5-(GSyl)-alpha-MeDA and 2,5-bis(GSyl)-alpha-MeDA, and to a lesser extent MDA and MDMA, induced a concentration and time-dependent increase in reactive oxygen species (ROS) in both hSERT and human dopamine transporter-transfected cells. Fluoxetine attenuated the increase in ROS generation in hSERT-expressing cells. The results are consistent with the view that the serotonergic neurotoxicity of MDA and MDMA may be mediated by the metabolism-dependent stimulation of DA transport into hSERT-expressing cells and ROS generation by redox active catechol-thioether metabolites and DA.\n\n\n                    Context: \n                    This section discusses the neurotoxic mechanisms of MDA and MDMA, highlighting their metabolism-dependent stimulation of dopamine transport via the human serotonin transporter (hSERT) and resulting reactive oxygen species (ROS) production. It provides experimental evidence for ROS involvement and the attenuation effects of fluoxetine, emphasizing their role in serotonergic neurotoxicity within the overall pharmacological and toxicological profile of these compounds.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_31", "document_index": 31, "latency_s": 1.085668200001237, "prompt_toks": 18088, "completion_toks": 96}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:15169827\n\nJones DC et al; J Pharmacol Exp Ther 311 (1): 298-306 (2004)\n\nMetabolites of 3,4-methylenedioxyamphetamine in the urine of dogs and monkeys were separated by gas-liquid chromatography as their trifluoroacetyl and/or n-butyl ether derivatives and identified by comparison of the chromatographic and mass spectrometric behavior of these derivatives with those of synthetic compounds. The metabolites identified in dog and monkey urine were alpha-methyldopamine, 3-O-methyl-alpha-methyldopamine, and 3,4-dihydroxybenzyl methyl ketone. The monkey urine also contained 3,4-methylenedioxybenzyl methyl ketone and 3,4-methylenedioxybenzoic acid present as a glucuronide and/or sulfate conjugate, whereas the dog urine had 3-methoxy-4-hydroxybenzoic acid present as a conjugate other than glucuronide and sulfate. The phenolic metabolites in both species were present free and as glucuronide and/or sulfate conjugates.\n\nPMID:33023\n\nMidha KK et al; Drug Metab Dispos 6 (6): 623-30 (1978)\n\n\n                    Context: \n                    This excerpt details the metabolic pathways and identified urine metabolites of 3,4-methylenedioxyamphetamine in dogs and monkeys, including compounds such as alpha-methyldopamine, 3-O-methyl-alpha-methyldopamine, and phenolic conjugates. It is relevant for understanding the biotransformation, metabolic profiling, and forensic analysis of the compound, supporting sections on metabolism, analytical methods, and toxicology within the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_32", "document_index": 31, "latency_s": 1.2222534000029555, "prompt_toks": 17949, "completion_toks": 99}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:33023\n\nMidha KK et al; Drug Metab Dispos 6 (6): 623-30 (1978)\n\n8.4 Mechanism of Action\n\nPhenylethylamines act on the peripheral and central nervous system by alpha- and beta-adrenergic stimulation. These compounds may also have varying degrees of serotonergic and dopaminergic activity, depending on structural similarity to mescaline. /Phenylethylamines/\n\nHaddad, L.M. (Ed). Clinical Management of Poisoning and Drug Overdose 3rd Edition. Saunders, Philadelphia, PA. 1998., p. 574\n\n\n                    Context: \n                    This excerpt details the mechanism of action for phenylethylamines, including compounds like MDA, highlighting their activity on alpha- and beta-adrenergic systems, serotonergic, and dopaminergic pathways. It references authoritative sources and situates this biochemical information within the broader context of chemical pharmacology, toxicity, and safety data covered in the full webpage. This information is relevant for understanding the neuropharmacological effects and toxicology of Tenamfetamine and related substances.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_33", "document_index": 31, "latency_s": 1.143061700000544, "prompt_toks": 18076, "completion_toks": 90}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    The effect of various analogues of the neurotoxic amphetamine derivative, MDA (3,4-methylenedioxyamphetamine) on carrier-mediated, calcium-independent release of 3H-5-HT and 3H-DA from rat brain synaptosomes was investigated. Both enantiomers of the neurotoxic analogues MDA and MDMA (3,4-methylenedioxymethamphetamine) induce synaptosomal release of 3H-5-HT and 3H-DA in vitro. The release of 3H-5-HT induced by MDMA is partially blocked by 10(-6) M fluoxetine. The (+) enantiomers of both MDA and MDMA are more potent than the (-) enantiomers as releasers of both 3H-5-HT and 3H-DA. ... Possible long-term serotonergic neurotoxicity was assessed by quantifying the density of 5-HT uptake sites in rats treated with multiple doses of selected analogues using 3H-paroxetine to label 5-HT uptake sites. In the neurotoxicity study of the compounds investigated, only (+)MDA caused a significant loss of 5-HT uptake sites in comparison to saline-treated controls. ...\n\nPMID:1829838\n\n\n                    Context: \n                    This passage details research on the neurotoxicity of MDA and its analogues, examining their effects on serotonin and dopamine release in rat brain synaptosomes and their long-term impact on 5-HT uptake sites. It highlights that only (+)MDA caused significant serotonergic neuron damage, emphasizing the differential neurotoxic potentials of these compounds. This information is relevant within the broader discussion of MDA's pharmacological and toxicological properties.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_34", "document_index": 31, "latency_s": 1.185760799999116, "prompt_toks": 17845, "completion_toks": 105}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:1829838\n\nMcKenna DJ et al; Pharmacol Biochem Behav 38 (3): 505-12 (1991)\n\n\n                    Context: \n                    This excerpt references a toxicological study by McKenna et al. (PMID:1829838) from 1991, which investigates the neurotoxicity and behavioral effects of MDA and related amphetamines in animal models. Its inclusion is relevant to the overall document as it provides detailed experimental data on MDA's toxicity mechanisms, complementing the comprehensive chemical, biological, and safety information about tenamfetamine and related compounds. This reference supports sections on toxicity, mechanisms of action, and safety hazards.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_35", "document_index": 31, "latency_s": 1.149788399998215, "prompt_toks": 18111, "completion_toks": 83}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    The effect of the R(-) and S(+) isomers of 3,4-methylenedioxyamphetamine (MDA) and its N-methyl analog 3,4-methylenedioxymethamphetamine (MDMA) on [3H]inositol monophosphate accumulation was studied in cells expressing either 5-HT2A or 5-HT2C receptors. The isomers of MDA produced a concentration dependent increase in phosphatidyl inositol (PI) hydrolysis at the 5-HT2A receptors, with the R(-) isomer of MDA being more potent than the S(+) at the 5-HT2A receptor. The R(-) and S(+) isomers of MDMA were significantly less efficacious at the 5-HT2A receptor as compared to MDA; S(+)MDMA had no effect. At the 5-HT2C receptor, both R(-) and S(+)MDA were equipotent at stimulating PI hydrolysis, with the S(+) isomer of MDMA being more efficacious at the 5-HT2C receptor compared with the R(-) isomer. In all cases at both the 5-HT2A and 5-HT2C receptors, the affinities of the isomers of MDMA and MDA were at least 2-3 orders of magnitude less than 5-HT. Despite the weak effect of these compounds\n\n\n                    Context: \n                    This excerpt describes the receptor activity of MDA and MDMA isomers at 5-HT2A and 5-HT2C receptors, highlighting their potency, efficacy, and binding affinity differences. It is relevant to the document's discussion of the pharmacological mechanisms and receptor interactions of these hallucinogenic compounds, emphasizing their weak affinity relative to serotonin. This information aids understanding of their intrinsic activity and neurotoxic potential.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_36", "document_index": 31, "latency_s": 1.2530521000007866, "prompt_toks": 17907, "completion_toks": 91}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    In all cases at both the 5-HT2A and 5-HT2C receptors, the affinities of the isomers of MDMA and MDA were at least 2-3 orders of magnitude less than 5-HT. Despite the weak effect of these compounds at the 5-HT2A and 5-HT2C receptors, these substituted amphetamines do possess intrinsic activity which may contribute to their neurotoxic effects when administered at high doses.\n\n\n                    Context: \n                    This excerpt summarizes the receptor binding and activity profile of MDMA and MDA, highlighting their low affinity for 5-HT2A and 5-HT2C receptors (2-3 orders of magnitude less than 5-HT). Despite weak receptor effects, it notes that these compounds have intrinsic activity that may contribute to neurotoxicity at high doses. It is relevant to sections discussing mechanisms of action and neurotoxicity, providing detailed pharmacological insights.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_37", "document_index": 31, "latency_s": 1.1463589999912074, "prompt_toks": 18086, "completion_toks": 89}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:7824160\n\nNash JF et al; Neurosci Lett 177 (1-2): 111-5 (1994)\n\n8.5 Transformations\n\n9 Use and Manufacturing\n\n9.1 Uses\n\nEPA CPDat Chemical and Product Categories\n\nThe Chemical and Products Database, a resource for exposure-relevant data on chemicals in consumer products, Scientific Data, volume 5, Article number: 180125 (2018), DOI:10.1038/sdata.2018.125\n\nThis is a /DEA/ Schedule I controlled substance.\n\n21 CFR 1308.11(d) (USDEA); U.S. National Archives and Records Administration's Electronic Code of Federal Regulations. Available from, as of March 20, 2008: https://www.ecfr.gov\n\n... Destroys serotonergic neurons and has been used for that purpose experimentally.\n\nWishart DS et al; DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006 1;34. Available from, as of Feb 11, 2008: https://redpoll.pharmacy.ualberta.ca/drugbank/\n\n9.1.1 Use Classification\n\nPharmaceuticals -> Illicit drugs and related compounds -> Transformation products\n\n\n                    Context: \n                    This chunk provides references to scientific literature and regulatory classifications related to the use, transformation, and research applications of 3,4-methylenedioxyamphetamine (Tenamfetamine). It highlights its status as a DEA Schedule I controlled substance, its experimental application in destroying serotonergic neurons, and its categorization as an illicit drug and transformation product in pharmaceutical research, supporting its detailed chemical and toxicological profile in the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_38", "document_index": 31, "latency_s": 1.0739128999994136, "prompt_toks": 18098, "completion_toks": 68}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    9.1.1 Use Classification\n\nPharmaceuticals -> Illicit drugs and related compounds -> Transformation products\n\nS66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448\n\nPharmaceuticals\n\nS72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664\n\n9.2 Methods of Manufacturing\n\nPrepn: C. Mannich, W. Jacobsogn, Ber. 43, 189 (1910); U. Baum et al., J. Pharm Sci 69, 192 (1980)\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 995\n\n9.3 General Manufacturing Information\n\nThis is a controlled substance (hallucinogen) 21CFR1308.11\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 995\n\nSynth amphetamine derivative with stimulant and hallucinogenic properties\n\n\n                    Context: \n                    This excerpt details the classification, manufacturing methods, and regulatory status of the compound, emphasizing its classification as an illicit drug and controlled substance. It provides key references and synthesis information relevant for chemical and regulatory research within the comprehensive chemical profile. These details are critical for understanding legal, synthesis, and use-related aspects of the compound in the overall database.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_39", "document_index": 31, "latency_s": 1.142302699998254, "prompt_toks": 18072, "completion_toks": 69}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Synth amphetamine derivative with stimulant and hallucinogenic properties\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 995\n\n10 Identification\n\n10.1 Analytic Laboratory Methods\n\nAnalyte: 3,4-methylenedioxyamphetamine; matrix: bulk material; procedure: capillary electrophoresis with ultraviolet detection at 210 nm and 230 nm\n\nWalker JA et al; J Forensic Sci 41: 824-829 (1996). As cited in: Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\nAnalyte: 3,4-methylenedioxyamphetamine; matrix: bulk material; procedure: high-performance liquid chromatography with ultraviolet detection at 254 nm\n\nLaw B et al; J Chromatogr 301: 165-172 (1984). As cited in: Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\n\n                    Context: \n                    This excerpt details laboratory analytic methods for identifying 3,4-methylenedioxyamphetamine, including capillary electrophoresis and high-performance liquid chromatography procedures with specific UV detection wavelengths. It references authoritative sources and citations, emphasizing standardized analytical techniques critical for chemical detection and forensic analysis within the comprehensive chemical profile provided in the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_40", "document_index": 31, "latency_s": 1.2334104000037769, "prompt_toks": 18080, "completion_toks": 78}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Law B et al; J Chromatogr 301: 165-172 (1984). As cited in: Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\nAnalyte: 3,4-methylenedioxyamphetamine; matrix: bulk material; procedure: capillary electrophoresis with ultraviolet detection at 200 nm\n\nVaresio E et al; Electrophoresis 18: 931-937 (1997). As cited in: Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\n10.2 Clinical Laboratory Methods\n\nHPLC determination in whole blood ... GC/MS determination in hair.\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 995\n\nAnalyte: 3,4-methylenedioxyamphetamine; matrix: tissue (hair), urine; procedure: capillary electrophoresis with ultraviolet detection at 200 nm; limit of detection: 37 ng/mL\n\n\n                    Context: \n                    This section details analytical methods for detecting 3,4-methylenedioxyamphetamine, including chromatographic techniques such as HPLC and capillary electrophoresis, with specific references to procedural parameters, detection limits, and cited sources. It provides crucial laboratory protocols and validation data essential for forensic and clinical analysis within the broader database of chemical and pharmacological information on this compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_41", "document_index": 31, "latency_s": 1.280406599995331, "prompt_toks": 18070, "completion_toks": 84}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Analyte: 3,4-methylenedioxyamphetamine; matrix: tissue (hair), urine; procedure: capillary electrophoresis with ultraviolet detection at 200 nm; limit of detection: 37 ng/mL\n\nTagliaro F et al; Electrophoresis 19: 42-50 (1998). As cited in: Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\nAnalyte: 3,4-methylenedioxyamphetamine; matrix: urine; procedure: high-performance liquid chromatography with photodiode array ultraviolet detection at 198 nm; limit of detection: 30 ng/mL\n\nHelmlin HJ, Brenneisen R; J Chromatogr 593: 87-94 (1992). As cited in: Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\nAnalyte: 3,4-methylenedioxyamphetamine; matrix: blood (serum), tissue (hair), urine; procedure: capillary electrophoresis with ultraviolet detection at 200 nm\n\n\n                    Context: \n                    This section details analytical laboratory methods for detecting 3,4-methylenedioxyamphetamine in biological samples, including capillary electrophoresis and high-performance liquid chromatography techniques. It provides specific procedures, detection wavelengths, limits of detection, and sources for blood, urine, tissue (hair), with citations from relevant chromatographic studies. This information is essential for forensic and clinical testing within the comprehensive chemical profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_42", "document_index": 31, "latency_s": 1.3033206999971299, "prompt_toks": 18099, "completion_toks": 90}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Analyte: 3,4-methylenedioxyamphetamine; matrix: blood (serum), tissue (hair), urine; procedure: capillary electrophoresis with ultraviolet detection at 200 nm\n\nFrost M et al; Electrophoresis 18: 1026-1034 (1997). As cited in: Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\nAnalyte: 3,4-methylenedioxyamphetamine; matrix: blood (plasma), saliva, tissue (brain), urine; procedure: high-performance liquid chromatography with ultraviolet detection at 235 nm\n\nBonate PL et al; J Liq Chromatogr 18: 3473-3494 (1995). As cited in: Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\n11 Safety and Hazards\n\n11.1 Hazards Identification\n\n11.1.1 GHS Classification\n\nPictogram(s)\n\nAcute Toxic\n\nIrritant\n\nSignal\n\nDanger\n\nGHS Hazard Statements\n\nH300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]\n\nH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]\n\n\n                    Context: \n                    This excerpt provides analytical methods for detecting 3,4-methylenedioxyamphetamine (MDA) in blood, tissue, saliva, and urine samples using capillary electrophoresis, high-performance liquid chromatography, and ultraviolet detection. It is part of the comprehensive safety, hazards, and analytical information section in the full document, supporting identification and toxicological assessment of the compound. Key hazard classifications include acute toxicity and skin irritation.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_43", "document_index": 31, "latency_s": 0.8631586999981664, "prompt_toks": 18063, "completion_toks": 46}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Acute Toxic\n\nIrritant\n\nSignal\n\nDanger\n\nGHS Hazard Statements\n\nH300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]\n\nH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]\n\nH319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]\n\nH335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]\n\nPrecautionary Statement Codes\n\nP261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501\n\n(The corresponding statement to each P-code can be found at the GHS Classification page.)\n\nECHA C&L Notifications Summary\n\nAggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.\n\n\n                    Context: \n                    This excerpt provides detailed chemical safety hazard information for tenamfetamine, including GHS hazard statements, precautionary codes, and ECHA notification summaries, crucial for understanding its toxicity profile and regulatory status within the comprehensive chemical data.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_44", "document_index": 31, "latency_s": 0.9038763999997173, "prompt_toks": 17970, "completion_toks": 50}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.\n\nInformation may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.\n\n11.1.2 Hazard Classes and Categories\n\nAcute Tox. 2 (100%)\n\nSkin Irrit. 2 (100%)\n\nEye Irrit. 2 (100%)\n\nSTOT SE 3 (100%)\n\n11.2 Accidental Release Measures\n\n11.2.1 Disposal Methods\n\n\n                    Context: \n                    This section summarizes hazard classification and safety measures related to tenamfetamine, including ECHA C&L inventory data, hazard classes with specific categories, and disposal methods, providing critical information for regulatory compliance and safety assessment within the comprehensive chemical profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_45", "document_index": 31, "latency_s": 1.0084949000010965, "prompt_toks": 17945, "completion_toks": 47}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11.1.2 Hazard Classes and Categories\n\nAcute Tox. 2 (100%)\n\nSkin Irrit. 2 (100%)\n\nEye Irrit. 2 (100%)\n\nSTOT SE 3 (100%)\n\n11.2 Accidental Release Measures\n\n11.2.1 Disposal Methods\n\nSRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.\n\n11.3 Regulatory Information\n\n11.3.1 FDA Requirements\n\n\n                    Context: \n                    This excerpt details hazard classification, disposal methods, and regulatory information related to the chemical, including FDA requirements, providing essential safety and compliance data within the broader chemical profile. It is relevant for understanding regulatory and safety measures associated with the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_46", "document_index": 31, "latency_s": 0.9725049999979092, "prompt_toks": 18007, "completion_toks": 60}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11.3 Regulatory Information\n\n11.3.1 FDA Requirements\n\n/DEA/ Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term \"isomer\" includes the optical, position and geometric isomers). 3,4-Methylenedioxyamphetamine (DEA Code Number: 7400) is included on this list.\n\n\n                    Context: \n                    This section provides regulatory classification details for psychoactive substances, specifically noting that 3,4-methylenedioxyamphetamine is designated as a DEA Schedule I controlled substance under the DEA Code Number 7400, highlighting its legal status and importance within the broader legal and safety information in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_47", "document_index": 31, "latency_s": 1.2163822000002256, "prompt_toks": 17994, "completion_toks": 95}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    21 CFR 1308.11(d) (USDEA); U.S. National Archives and Records Administration's Electronic Code of Federal Regulations. Available from, as of February 27, 2008: https://www.ecfr.gov\n\n12 Toxicity\n\n12.1 Toxicological Information\n\n12.1.1 Acute Effects\n\n12.1.2 Interactions\n\nDesigner drugs of the amphetamine type (eg, ... MDA) ... have gained popularity and notoriety as rave drugs. ... A variety of adverse effects have been associated with the use/abuse of this class of drugs in humans, including a life-threatening serotonin syndrome, hepatotoxicity, neurotoxicity, and psychopathology.\n\nPMID:15228152\n\nMaurer HH et al; Ther Drug Monit 26 (2): 127-31 (April 2004)\n\n\n                    Context: \n                    This excerpt provides regulatory and toxicological information on 3,4-methylenedioxyamphetamine (MDA), highlighting relevant US legal classification under 21 CFR 1308.11(d) and summarizing adverse effects such as serotonin syndrome, hepatotoxicity, and neurotoxicity, supported by a key reference. It is essential for understanding the legal status and toxicological risks associated with this compound within the broader scientific and safety data presented in the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_48", "document_index": 31, "latency_s": 1.0633502999990014, "prompt_toks": 18070, "completion_toks": 94}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Lethality to both isolated and aggregated mice was determined for graded ip doses of d-amphetamine, dl-4-methoxyamphetamine (PMA), dl-2,5-dimethoxyamphetamine (DMA), dl-2,5-dimethoxy-4-bromoamphetamine (DOB), dl-2,5-dimethoxy-4-methylamphetamine (DOM) and dl-3,4-methylenedioxyamphetamine (MDA). Haloperidol (2.0 mg/kg), propranolol (10 mg/kg) and phenoxybenzamine (30 mg/kg) were tested for ability to antagonize the lethal effects of amphetamine and its derivatives. Considerable protection against amphetamine lethality was produced by haloperidol in both isolated and aggregated mice and by phenoxybenzamine in isolated mice, but propranolol was ineffective. An equivalent degree of protection was not achieved by use of any of the three agents before PMA, DMA or DOB. Protection against DOM was achieved only with phenoxybenzamine and only for isolated mice. Extensive protection against MDA was supplied by both phenoxybenzamine and propranolol for either condition of housing. ...\n\n\n                    Context: \n                    This excerpt details toxicological studies on the lethal effects of various methoxyamphetamine derivatives and related compounds, assessing the protective effects of different antagonists such as haloperidol, propranolol, and phenoxybenzamine. It is relevant to the document's comprehensive discussion of the toxicity, mechanism of action, and protective agents associated with MDA and related stimulant hallucinogens. Key findings include differential protection profiles depending on the compound and agent used.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_49", "document_index": 31, "latency_s": 1.071797399999923, "prompt_toks": 18029, "completion_toks": 77}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:687391\n\nDavis WM et al; Res Commun Chem Pathol Pharmacol 21 (1): 27-36 (1978)\n\n12.1.3 Antidote and Emergency Treatment\n\nImmediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/\n\nCurrance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3Rd edition, Elsevier Mosby, St. Louis, MO 2005, p. 160\n\n\n                    Context: \n                    This excerpt provides emergency antidote and first aid procedures for overdose or exposure to the compound, highlighting immediate response steps such as decontamination, artificial respiration, eye flushing, and avoidance of vomiting. It references authoritative sources and emphasizes urgent medical attention and supportive care, making it relevant for safety, toxicity, and medical management sections within the comprehensive chemical profile of Tenamfetamine.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_50", "document_index": 31, "latency_s": 1.0086100000044098, "prompt_toks": 18059, "completion_toks": 68}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3Rd edition, Elsevier Mosby, St. Louis, MO 2005, p. 160\n\nBasic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/\n\n\n                    Context: \n                    This excerpt provides detailed emergency treatment protocols for managing hazardous materials exposure, including airway management, oxygen administration, shock and seizure monitoring, eye irrigation, and decontamination procedures, relevant for toxicology and poison control sections in the comprehensive chemical safety document. It emphasizes immediate first aid steps and precautions, supporting clinical response guidelines within the full resource.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_51", "document_index": 31, "latency_s": 1.144189999991795, "prompt_toks": 17869, "completion_toks": 63}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3Rd edition, Elsevier Mosby, St. Louis, MO 2005, p. 160\n\n\n                    Context: \n                    This citation provides detailed emergency medical procedures and first aid guidelines for handling exposure to hazardous substances, including toxicological management of compounds like tenamfetamine. Its inclusion within the full webpage indicates the document's comprehensive coverage of chemical safety, toxicity, and emergency response protocols relevant for researchers and healthcare professionals addressing such substances.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_52", "document_index": 31, "latency_s": 1.2352611000096658, "prompt_toks": 18011, "completion_toks": 90}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W /SRP: \"To keep open\", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poisons A and B/\n\n\n                    Context: \n                    This chunk provides detailed emergency treatment protocols for severe poisoning or overdose cases involving the substance, including airway management, ventilation, fluid administration, seizure control, and supportive care. It is relevant to the overall document's section on toxicity, safety, and clinical management, highlighting specific first aid and hospital procedures essential for healthcare professionals handling acute intoxication. Key details include intubation, ventilation techniques, fluid support, seizure medications, and precautions for fluid overload.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_53", "document_index": 31, "latency_s": 1.170555400007288, "prompt_toks": 17871, "completion_toks": 84}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3Rd edition, Elsevier Mosby, St. Louis, MO 2005, p. 160-1\n\n\n                    Context: \n                    This citation references the emergency medical procedures and first aid guidelines for toxic substance exposure discussed within the comprehensive toxicity and safety information of the main webpage. It provides detailed protocols for decontamination, supportive care, and treatment of individuals affected by hazardous chemicals such as Tenamfetamine, supporting the document's focus on toxicity management. Its placement emphasizes clinical handling and emergency response relevant to the compound’s hazards outlined throughout the webpage.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_54", "document_index": 31, "latency_s": 1.2992520999978296, "prompt_toks": 18028, "completion_toks": 101}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Maintain an open airway and assist ventilation if necessary. Treat agitation, seizures, coma, and hyperthermia if they occur. benzodiazepines are usually satisfactory for treatment of agitation, although butyrophenones may also be used. Continuously monitor the temperature, other vital signs, and ECG for a minimum of 6 hours. There is no specific antidote. Hypertension is best treated by sedation and, if this is not effective, a parenteral vasodilator such as phentolamine or nitroprusside. Treat tachycardia with propranolol or esmolol. ... Decontamination: administer activated charcoal orally if conditions are appropriate. Gastric lavage is not necessary after small to moderate ingestions if activated charcoal can be given promptly. Consider whole-bowel irrigation and repeat doses of charcoal after ingestion of drug filled packets (\"body stuffers\"). Enhanced elimination: Dialysis and hemoperfusion are not effective. Repeat-dose charcoal has not been studied. ... /Amphetamines/\n\n\n                    Context: \n                    This excerpt provides emergency treatment and decontamination procedures for acute poisoning with amphetamines like tenamfetamine, highlighting supportive care, monitoring, and the ineffectiveness of dialysis and hemoperfusion. It is relevant within the document’s comprehensive toxicological profile, pharmacology, and safety considerations for the compound. Key details include managing agitation, hyperthermia, hypertension, and tachycardia, as well as the use of activated charcoal and the lack of a specific antidote.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_55", "document_index": 31, "latency_s": 1.2033557999966433, "prompt_toks": 18073, "completion_toks": 75}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Olson, K.R. (Ed.); Poisoning & Drug Overdose. 5th ed. Lange Medical Books/McGraw-Hill. New York, N.Y. 2007., p. 75\n\nTreatment is aggressive and supportive with careful attention to temperature, blood pressure and seizure control. ...\n\nPMID:3285124\n\nBuchanan JF, Brown CR; Med Toxicol Adverse Drug Exp 3 (1): 1-17 (1988)\n\n12.1.4 Human Toxicity Excerpts\n\n/SIGNS AND SYMPTOMS/ ... In overdose the differences between methamphetamine, 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) blur and the clinical presentation is similar to that of amphetamine overdose characterized by tachycardia, hypertension, hyperthermia, diaphoresis, mydriasis, agitation, muscle rigidity, and hyper-reflexia. Death usually results from arrhythmias, hyperthermia or intracerebral haemorrhage. Treatment is aggressive and supportive with careful attention to temperature, blood pressure and seizure control. ...\n\nPMID:3285124\n\n\n                    Context: \n                    This excerpt provides detailed information on the human toxic effects, signs and symptoms, and treatment approaches for overdose of methylenedioxyamphetamine (MDA), highlighting clinical presentation similar to amphetamine poisoning and emphasizing supportive care focusing on temperature, blood pressure, and seizure management. It is relevant within the document's sections on toxicity, clinical effects, and emergency treatment of the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_56", "document_index": 31, "latency_s": 0.9476052999962121, "prompt_toks": 18037, "completion_toks": 68}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:3285124\n\nBuchanan JF, Brown CR; Med Toxicol Adverse Drug Exp 3 (1): 1-17 (1988)\n\n/SIGNS AND SYMPTOMS/ Central nervous system effects may be secondary to both sympathetic stimulation and altered perception. Therapeutic or recreational doses may induce feelings of warmth and are purported to promote communication and empathy. Higher doses may induce hallucinations, agitation, delirium, hyperreflexia, or rigidity. Seizures may occur and can reflect either direct CNS stimulation or hypertension induced cerebrovascular hemorrhage. Sympathetic stimulation may induce a state of hyperthermia and agitated delirium. Direct sympathetic stimulation and increased metabolic heat production may be the primary pathophysiologic event; however, in many cases, increased muscular activity may be contributory as well. /Phenylethylamines/\n\nHaddad, L.M. (Ed). Clinical Management of Poisoning and Drug Overdose 3rd Edition. Saunders, Philadelphia, PA. 1998., p. 574\n\n\n                    Context: \n                    This excerpt summarizes clinical signs and neurological effects associated with phenylethylamine derivatives like MDA, including CNS stimulation, hallucinations, seizures, and hyperthermia, as documented in toxicology references. It highlights important symptoms relevant for diagnosis and management of overdose cases within the broader chemical and pharmacological profile of tenamfetamine.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_57", "document_index": 31, "latency_s": 1.5875712999986717, "prompt_toks": 17970, "completion_toks": 97}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Haddad, L.M. (Ed). Clinical Management of Poisoning and Drug Overdose 3rd Edition. Saunders, Philadelphia, PA. 1998., p. 574\n\n/SIGNS AND SYMPTOMS/ Cardiovascular effects generally reflect sympathetic stimulation. Systolic and diastolic hypertension can be seen. Plus can be variably affected. Tachycardia can be seen; however if alpha-adrenergic effects predominate, hypertension with reflex bradycardia can occur. /Phenylethylamines/\n\nHaddad, L.M. (Ed). Clinical Management of Poisoning and Drug Overdose 3rd Edition. Saunders, Philadelphia, PA. 1998., p. 574\n\n\n                    Context: \n                    This excerpt provides detailed information on the cardiovascular signs and symptoms associated with phenylethylamines, including sympathomimetic effects such as hypertension and tachycardia, as described in Haddad's clinical toxicology reference. Its relevance to the overall document lies in outlining the physiological manifestations of Tenamfetamine, a phenylethylamine derivative, aiding in understanding its toxic profile and clinical management. Key details include the effects of sympathetic stimulation and potential cardiovascular responses.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_58", "document_index": 31, "latency_s": 1.41819559999567, "prompt_toks": 18012, "completion_toks": 88}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Haddad, L.M. (Ed). Clinical Management of Poisoning and Drug Overdose 3rd Edition. Saunders, Philadelphia, PA. 1998., p. 574\n\n/CASE REPORTS/ ... In this case /investigators/ detail a divided dose of 850 mg of MDA ingested within 2 hr and 15 min /which/ was sufficient to cause the death of a 24-year-old male, 4 hr after the final dose. The symptoms of MDA intoxication exhibited by the decedent prior to death closely mimic those of acute amphetamine poisoning: profuse sweating, violent and irrational behavior, and stereotypically compulsive behavior. While the methaqualone may have contributed to the demise of the decedent ... the MDA itself was sufficient to cause death. ...\n\nPMID:512617\n\nPoklis A et al; J Forensic Sci 24 (1): 70-5 (1979)\n\n\n                    Context: \n                    This excerpt details a case report of a 24-year-old male who died after ingesting a divided 850 mg dose of MDA within 2 hours and 15 minutes, highlighting MDA's acute toxicity and potential for fatal overdose. It emphasizes symptoms similar to amphetamine poisoning and confirms MDA's lethal capacity, situating this within the broader discussion of MDA's toxicological profile and human overdose risks covered in the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_59", "document_index": 31, "latency_s": 1.390761599992402, "prompt_toks": 17980, "completion_toks": 83}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:512617\n\nPoklis A et al; J Forensic Sci 24 (1): 70-5 (1979)\n\n/CASE REPORTS/ ...The following symptoms were found in a patient /following Methylenedioxyamphetamine exposure/: sympathomimetic effects, coma, seizures, hyperreflexia, and hyperthermia. The patient's condition was initially stabilized and then deteriorated with uncontrollable hyperthermia, hematologic abnormalities, and coma that culminated in death. ... The concept that this drug is primarily a hallucinogen with mild toxicity is erroneous.\n\nPMID:7283563\n\nSimpson DL, Rumack BH; Arch Intern Med 141 (11): 1507-9 (1981)\n\n12.1.5 Non-Human Toxicity Excerpts\n\n\n                    Context: \n                    This excerpt provides critical case report data on the acute toxicity of methylenedioxyamphetamine, highlighting symptoms such as sympathomimetic effects, coma, seizures, hyperreflexia, hyperthermia, and cases of death, countering the misconception that it has only mild toxicity. It supplements the broader pharmacological and toxicological overview, emphasizing the drug's dangerous potential and the importance of accurate toxicity information.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_60", "document_index": 31, "latency_s": 1.351969099996495, "prompt_toks": 18079, "completion_toks": 86}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    /LABORATORY ANIMALS: Acute Exposure/ ... A single 1.8 mg/kg dose of MDA produced 30 to 64% increases in the 5-HT content of frontal cortex from 30 to 120 min after injection and a decrease in 5-HT turnover from 30 min to 8 hr, but had no effect in hippocampus, caudate nucleus, or hypothalamus /of rabbits/. A single 3.6 mg/kg dose of MDA also reduced the turnover of 5-HT in frontal cortex, but this was accompanied by a decrease in 5-HIAA with no increase in 5-HT. The 1.8 and 3.6 mg/kg doses of MDA had no significant or consistent effects on the contents of DA, DOPAC, HVA, and NE in any brain area examined. Chronic administration of MDA (3.6 mg/kg/day for 4 days) failed to produce any evidence of a neurotoxic action on 5-HT neurons. Higher doses could not be employed because the LD50 of MDA was approximately 5 mg/kg. This study has demonstrated that behaviorally effective and nonneurotoxic doses of MDA produce increases in the content and decreases in turnover of 5-HT in frontal cortex\n\n\n                    Context: \n                    This excerpt details findings from non-human animal studies on acute MDA exposure, highlighting effects on serotonergic neurons in rabbit brain regions, particularly increases in 5-HT content and decreased turnover in the frontal cortex at doses up to 3.6 mg/kg, with no neurotoxicity observed at these levels. It provides relevant experimental toxicity data supporting the document's broader discussion on MDA's neurochemical effects and safety profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_61", "document_index": 31, "latency_s": 1.4395688000076916, "prompt_toks": 17868, "completion_toks": 74}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    was approximately 5 mg/kg. This study has demonstrated that behaviorally effective and nonneurotoxic doses of MDA produce increases in the content and decreases in turnover of 5-HT in frontal cortex that resemble those of other hallucinogens such as LSD and DOM.\n\n\n                    Context: \n                    This excerpt summarizes toxicological findings on MDA doses around 5 mg/kg, highlighting that behaviorally effective, nonneurotoxic doses can alter serotonergic (5-HT) levels in the frontal cortex similarly to other hallucinogens like LSD and DOM, which is relevant to the document's discussion of MDA's neurotoxicity and neurochemical effects.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_62", "document_index": 31, "latency_s": 1.394867199996952, "prompt_toks": 17844, "completion_toks": 102}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:7532309\n\nRomano AG et al; Pharmacol Biochem Behav 49 (3): 599-607 (1994)\n\n\n                    Context: \n                    This excerpt references a 1994 study by Romano AG et al that investigates the neurotoxic effects of methylenedioxyamphetamine (MDA) in laboratory animals, specifically its impact on serotonergic neurons. It provides toxicological data and mechanistic insights relevant to the detailed toxicity, metabolism, and safety information included in the full document about MDA and related compounds. This study is crucial for understanding the compound's neurotoxicity profile and contributes to the comprehensive toxicological assessment presented here.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_63", "document_index": 31, "latency_s": 1.0394349999987753, "prompt_toks": 18051, "completion_toks": 83}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    /LABORATORY ANIMALS: Acute Exposure/ ... In rats, /3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA)/ cause large reductions in brain levels of serotonin (5-HT). This study employs immunocytochemistry to characterize the neurotoxic effects of these compounds upon monoaminergic neurons in the rat brain. Two weeks after systemic administration of MDA or MDMA (20 mg/kg, sc, twice daily for 4 d), there is profound loss of serotonergic (5-HT) axons throughout the forebrain; catecholamine axons are completely spared. Regional differences in drug toxicity are exemplified by partial sparing of 5-HT axons in hippocampus, lateral hypothalamus, basal forebrain, and in some areas of neocortex. The terminals of 5-HT axons are selectively ablated, while axons of passage and raphe cell bodies are spared. Thickened preterminal fibers exhibit increased staining due to damming-up of neurotransmitter and other axonal constituents. Fine 5-HT axon terminals are extremely\n\n\n                    Context: \n                    This excerpt details the neurotoxic effects of MDA and MDMA on serotonergic neurons in rats, highlighting significant reductions in brain serotonin (5-HT) levels, selective ablation of 5-HT axon terminals, and regional differences in toxicity. It emphasizes that serotonin pathways are specifically targeted while catecholamine neurons remain spared, providing critical insights into the neurotoxicity profiles discussed across the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_64", "document_index": 31, "latency_s": 0.9541922000062186, "prompt_toks": 17974, "completion_toks": 84}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    and raphe cell bodies are spared. Thickened preterminal fibers exhibit increased staining due to damming-up of neurotransmitter and other axonal constituents. Fine 5-HT axon terminals are extremely vulnerable to these drugs, whereas terminal-like axons with large varicosities survive, raising the possibility that some 5-HT axons may be resistant to the neurotoxic effects. At short survivals, visualization of greatly swollen, fragmented 5-HT axons provides anatomic evidence for degeneration of 5-HT projections. The results establish that MDA and MDMA produce structural damage to 5-HT axon terminals followed by lasting denervation of the forebrain. Both drugs have similar effects, but MDA produces a greater reduction of 5-HT axons than does MDMA at the same dosage. ...\n\n\n                    Context: \n                    This excerpt details the neurotoxic effects of MDA and MDMA on serotonergic (5-HT) axons in the rat brain, highlighting their structural damage and differential impact on terminal fibers. It emphasizes the specificity of neurodegeneration to terminal-like axons with large varicosities and provides evidence of lasting forebrain denervation, which is central to understanding the drugs' neurotoxicity discussed throughout the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_65", "document_index": 31, "latency_s": 0.9345433999988018, "prompt_toks": 17967, "completion_toks": 82}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:2457659\n\nO'Hearn E et al; J Neurosci 8 (8): 2788-803 (1988)\n\n/LABORATORY ANIMALS: Acute Exposure/ A high intravenous (i.v.) dose of MDA (20 mg/kg) to mongrel dogs elevated body temperature, heart rate, mean arterial pressure and other cardiovascular parameters initially, but only the 1st two remained high. Other functions soon became quite depressed, and death shortly ensued. Arterial pO2 decreased, but pH and pCO2 showed a biphasic response after an initial decrease ...\n\nPMID:3699443\n\nDavis WM et al; Gen Pharmacol 17 (2): 179-83 (1986)\n\n\n                    Context: \n                    This chunk provides experimental data on the acute toxicity of MDA in laboratory animals, specifically noting high-dose intravenous effects in mongrel dogs leading to hyperthermia, cardiovascular depression, and eventual death, as detailed in studies by O'Hearn et al. and Davis et al. It is relevant for understanding the toxicological profile and safety concerns associated with MDA within the comprehensive chemical and pharmacological information.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_66", "document_index": 31, "latency_s": 0.9186163999984274, "prompt_toks": 18043, "completion_toks": 73}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    /LABORATORY ANIMALS: Acute Exposure/ Body temperature and spontaneous home cage activity were monitored continuously in six male rhesus monkeys via radiotelemetric devices. The subjects were challenged intramuscularly with 0.56-2.4 mg/kg MDMA, 0.56-2.4 mg/kg MDA and 0.1-1.0 mg/kg METH. All three amphetamines significantly elevated temperature; however the timecourse of effects differed. The acute effect of METH lasted hours longer than MDA or MDMA and a disruption of nighttime circadian cooling was observed as long as 18 hours after 1.0 mg/kg METH and 1.78-2.4 mg/kg MDA, but not after MDMA. Activity levels were only reliably increased by 0.32 mg/kg METH. It is concluded that while all three substituted amphetamines produce hyperthermia in rhesus monkeys, the effects do not depend on elevated locomotor activity and exhibit differences between compounds. The results highlight physiological risks posed both by recreational use of the amphetamines and by current trials for clinical MDMA\n\n\n                    Context: \n                    This excerpt details a study on the acute effects of MDMA, MDA, and METH on body temperature and activity levels in rhesus monkeys, highlighting differences in their duration and impact on circadian rhythms. It is relevant to the document's broader discussion of the pharmacological and toxicological properties of these substituted amphetamines, emphasizing their physiological risks and behavioral effects.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_67", "document_index": 31, "latency_s": 1.2259055999893462, "prompt_toks": 17846, "completion_toks": 84}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    locomotor activity and exhibit differences between compounds. The results highlight physiological risks posed both by recreational use of the amphetamines and by current trials for clinical MDMA use.\n\n\n                    Context: \n                    This excerpt summarizes research findings on the effects of various amphetamine compounds, including MDMA, highlighting their impact on locomotor activity and associated physiological risks. It is relevant to the document's discussion of the toxicological and pharmacological profiles of Tenamfetamine and related substances, emphasizing safety concerns for both recreational and clinical use of these compounds. The details underscore the neurotoxic and physiological effects detailed throughout the full report.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_68", "document_index": 31, "latency_s": 1.0838208999921335, "prompt_toks": 18110, "completion_toks": 83}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:16876329\n\nFull text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1853374\n\nCrean RD et al; Neuroscience 142(2): 515-525 (2006)\n\nFor more Non-Human Toxicity Excerpts (Complete) data for 3,4-METHYLENEDIOXYAMPHETAMINE (7 total), please visit the HSDB record page.\n\n12.1.6 Non-Human Toxicity Values\n\nLD50 Mouse oral 13,300 ug/kg\n\nLewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2438\n\nLD50 Mouse ip 82,300 ug/kg\n\nLewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2438\n\nLD50 Mouse ip 68 mg/kg /hydrochloride/\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 996\n\nLD50 Mouse iv 31,100 ug/kg\n\n\n                    Context: \n                    This excerpt provides detailed non-human toxicity data, including LD50 values in mice via oral, intraperitoneal, and intravenous routes, referencing authoritative sources such as Sax's Dangerous Properties of Industrial Materials and The Merck Index. It is relevant for researchers assessing toxicological thresholds and safety profiles of 3,4-methylenedioxyamphetamine within the broader chemical and pharmacological profile presented in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_69", "document_index": 31, "latency_s": 1.0966212999919662, "prompt_toks": 18097, "completion_toks": 71}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 996\n\nLD50 Mouse iv 31,100 ug/kg\n\nLewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2438\n\nFor more Non-Human Toxicity Values (Complete) data for 3,4-METHYLENEDIOXYAMPHETAMINE (7 total), please visit the HSDB record page.\n\n12.1.7 Populations at Special Risk\n\n... Phenylisopropylamines as a class interact with CYP2D6 as substrates and/or inhibitors. Their use may cause metabolic interactions with other drugs that are CYP2D6 substrates, and the potential for polymorphic oxidation via CYP2D6 may be a source of interindividual variation in their abuse liability and toxicity.\n\nPMID:9264312\n\nWu D et al; Biochem Pharmacol 53 (11): 1605-12 (1997)\n\n12.2 Ecological Information\n\n12.2.1 Environmental Water Concentrations\n\n\n                    Context: \n                    This segment provides detailed toxicity data, including LD50 values and references from authoritative sources like The Merck Index and Sax's Dangerous Properties of Industrial Materials. It highlights considerations for populations at risk due to CYP2D6 interactions and includes environmental water concentration insights, making it relevant for toxicity assessment, environmental impact, and risk evaluation within the comprehensive chemical profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_70", "document_index": 31, "latency_s": 1.0965036999987205, "prompt_toks": 18047, "completion_toks": 82}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:9264312\n\nWu D et al; Biochem Pharmacol 53 (11): 1605-12 (1997)\n\n12.2 Ecological Information\n\n12.2.1 Environmental Water Concentrations\n\nWhile data specific to 3,4-methylenedioxyamphetamine were not located(SRC, 2008), the literature suggests that some pharmaceutically active compounds originating from human and veterinary therapy are not eliminated completely in municipal sewage treatment plants and are therefore discharged into receiving waters(1). Wastewater treatment processes often were not designed to remove them from the effluent(2). Selected organic waste compounds may be degrading to new and more persistent compounds that may be released instead of or in addition to the parent compound(2). Studies have indicated that several polar pharmaceutically active compounds can leach through soils(1).\n\n(1) Heberer T; Tox Lett 131: 5-17 (2002)\n\n(2) Koplin DW et al; Environ Sci Toxicol 36: 1202-211 (2002)\n\n13 Associated Disorders and Diseases\n\n14 Literature\n\n\n                    Context: \n                    This section provides ecological and environmental data related to 3,4-methylenedioxyamphetamine, including its presence in water sources and water contamination concerns, referencing studies on pharmaceutical compound persistence and leaching. It is relevant for understanding environmental exposure risks associated with this compound, complementing the document's comprehensive chemical, toxicological, and regulatory information. The included references highlight key research on environmental distribution and degradation.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_71", "document_index": 31, "latency_s": 1.1874700999906054, "prompt_toks": 18091, "completion_toks": 91}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (1) Heberer T; Tox Lett 131: 5-17 (2002)\n\n(2) Koplin DW et al; Environ Sci Toxicol 36: 1202-211 (2002)\n\n13 Associated Disorders and Diseases\n\n14 Literature\n\n14.1 Consolidated References\n\n14.2 NLM Curated PubMed Citations\n\n14.3 Springer Nature References\n\n14.4 Thieme References\n\n14.5 Chemical Co-Occurrences in Literature\n\n14.6 Chemical-Gene Co-Occurrences in Literature\n\n14.7 Chemical-Disease Co-Occurrences in Literature\n\n15 Patents\n\n15.1 Depositor-Supplied Patent Identifiers\n\nLink to all deposited patent identifiers\n\n15.2 WIPO PATENTSCOPE\n\nPatents are available for this chemical structure:\n\nhttps://patentscope.wipo.int/search/en/result.jsf?inchikey=NGBBVGZWCFBOGO-UHFFFAOYSA-N\n\n15.3 Chemical Co-Occurrences in Patents\n\n15.4 Chemical-Disease Co-Occurrences in Patents\n\n15.5 Chemical-Gene Co-Occurrences in Patents\n\n16 Interactions and Pathways\n\n16.1 Chemical-Target Interactions\n\n16.2 Drug-Drug Interactions\n\n17 Biological Test Results\n\n17.1 BioAssay Results\n\n18 Classification\n\n\n                    Context: \n                    This section provides references and external links related to environmental toxicity studies, patent information, and literature sources pertinent to the chemical compound. It includes citations such as Heberer T (2002) and Koplin DW (2002), along with links to patent databases, chemical co-occurrence resources, and bibliographic references, forming a key part of the document's comprehensive data on chemical safety, intellectual property, and scientific literature for research and retrieval purposes.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_72", "document_index": 31, "latency_s": 1.2041841999889584, "prompt_toks": 18071, "completion_toks": 96}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    16 Interactions and Pathways\n\n16.1 Chemical-Target Interactions\n\n16.2 Drug-Drug Interactions\n\n17 Biological Test Results\n\n17.1 BioAssay Results\n\n18 Classification\n\n18.1 MeSH Tree\n\n18.2 NCI Thesaurus Tree\n\n18.3 ChEBI Ontology\n\n18.4 KEGG: Target-based Classification of Drugs\n\n18.5 ChemIDplus\n\n18.6 ChEMBL Target Tree\n\n18.7 UN GHS Classification\n\n18.8 EPA CPDat Classification\n\n18.9 NORMAN Suspect List Exchange Classification\n\n18.10 EPA DSSTox Classification\n\n18.11 EPA Substance Registry Services Tree\n\n18.12 MolGenie Organic Chemistry Ontology\n\n19 Information Sources\n\nCAS Common Chemistry\n\nLICENSE\n\nThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.\n\nhttps://creativecommons.org/licenses/by-nc/4.0/\n\n3,4-Methylenedioxyamphetamine\n\nhttps://commonchemistry.cas.org/detail?cas_rn=4764-17-4\n\nChemIDplus\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nTenamfetamine [INN]\n\n\n                    Context: \n                    This section details the interactions, classifications, and sources related to 3,4-methylenedioxyamphetamine, including chemical-target and drug-drug interactions, bioassay results, and classification hierarchies such as MeSH, NCI Thesaurus, KEGG, and EPA categories. It also lists authoritative sources like CAS Common Chemistry and ChemIDplus with licensing information, providing comprehensive data for research and retrieval of chemical and pharmacological information about the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_73", "document_index": 31, "latency_s": 1.011482599991723, "prompt_toks": 18075, "completion_toks": 76}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    3,4-Methylenedioxyamphetamine\n\nhttps://commonchemistry.cas.org/detail?cas_rn=4764-17-4\n\nChemIDplus\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nTenamfetamine [INN]\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0004764174\n\nChemIDplus Chemical Information Classification\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/chemidplus\n\nDrugBank\n\nLICENSE\n\nCreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)\n\nhttps://www.drugbank.ca/legal/terms_of_use\n\nTenamfetamine\n\nhttps://www.drugbank.ca/drugs/DB01509\n\nEPA DSSTox\n\nLICENSE\n\nhttps://www.epa.gov/privacy/privacy-act-laws-policies-and-resources\n\n(+/-)-3,4-(Methylenedioxy)amphetamine\n\nhttps://comptox.epa.gov/dashboard/DTXSID40859958\n\nCompTox Chemicals Dashboard Chemical Lists\n\nhttps://comptox.epa.gov/dashboard/chemical-lists/\n\nEuropean Chemicals Agency (ECHA)\n\nLICENSE\n\n\n                    Context: \n                    This chunk provides key identifiers, licensing information, and external resource links for 3,4-Methylenedioxyamphetamine (Tenamfetamine), supplementing the comprehensive chemical data and regulatory details found throughout the full webpage. It is relevant for locating authoritative sources, licensing terms, and chemical registration details to support research, regulatory, or analytical searches related to this compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_74", "document_index": 31, "latency_s": 1.1087007999885827, "prompt_toks": 18022, "completion_toks": 91}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://comptox.epa.gov/dashboard/DTXSID40859958\n\nCompTox Chemicals Dashboard Chemical Lists\n\nhttps://comptox.epa.gov/dashboard/chemical-lists/\n\nEuropean Chemicals Agency (ECHA)\n\nLICENSE\n\nUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: \"Source: European Chemicals Agency, http://echa.europa.eu/\". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.\n\nhttps://echa.europa.eu/web/guest/legal-notice\n\n\n                    Context: \n                    This chunk provides licensing and usage information related to chemical data sourced from the European Chemicals Agency (ECHA), including conditions for reproduction, distribution, and linking. It situates within the full webpage context by detailing legal restrictions and authorizations relevant to the chemical identifiers and data references, such as the ComTox Chemicals Dashboard (DTXSID40859958). This ensures legal clarity and metadata consistency for researchers accessing or sharing ECHA-derived chemical information.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_75", "document_index": 31, "latency_s": 1.2347778000112157, "prompt_toks": 18078, "completion_toks": 88}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://echa.europa.eu/web/guest/legal-notice\n\n4764-17-4\n\nhttps://echa.europa.eu/substance-information/-/substanceinfo/100.230.706\n\n803-951-7\n\nhttps://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/237271\n\nFDA Global Substance Registration System (GSRS)\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nTENAMFETAMINE\n\nhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/XJZ28FJ27W\n\nHazardous Substances Data Bank (HSDB)\n\nLICENSE\n\nhttps://www.nlm.nih.gov/web_policies.html\n\n3,4-METHYLENEDIOXYAMPHETAMINE\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/hsdb/7593\n\n\n                    Context: \n                    This chunk provides authoritative regulatory and chemical identifiers for tenamfetamine (CAS: 4764-17-4, EC: 803-951-7), including links to ECHA substance information and FDA GSRS licensing details. It is essential for regulatory compliance, chemical registration, and safety assessment within the comprehensive PubChem data on this compound. The information supports search retrieval related to chemical registration, legal notices, and safety databases.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_76", "document_index": 31, "latency_s": 1.5862140999961412, "prompt_toks": 18092, "completion_toks": 101}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Hazardous Substances Data Bank (HSDB)\n\nLICENSE\n\nhttps://www.nlm.nih.gov/web_policies.html\n\n3,4-METHYLENEDIOXYAMPHETAMINE\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/hsdb/7593\n\nHuman Metabolome Database (HMDB)\n\nLICENSE\n\nHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.\n\nhttp://www.hmdb.ca/citing\n\n3,4-Methylenedioxyamphetamine\n\nhttp://www.hmdb.ca/metabolites/HMDB0041931\n\nHMDB0041931_msms_2238500\n\nhttps://hmdb.ca/metabolites/HMDB0041931#spectra\n\nChEBI\n\n3,4-Methylenedioxyamphetamine\n\nhttps://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:166520\n\nChEBI Ontology\n\nhttp://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology\n\n\n                    Context: \n                    This excerpt provides curated chemical and biological data sources related to 3,4-methylenedioxyamphetamine (MDA), including regulatory licenses, source links, and metabolite information from the Human Metabolome Database (HMDB) and ChEBI. It complements the comprehensive full webpage by focusing on authoritative references, licensing, and external database links relevant for research, legal, and safety considerations of the compound. This contextualizes MDA’s regulatory and metabolic information within the broader data set.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_77", "document_index": 31, "latency_s": 1.2491454999981215, "prompt_toks": 18084, "completion_toks": 89}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ChEBI\n\n3,4-Methylenedioxyamphetamine\n\nhttps://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:166520\n\nChEBI Ontology\n\nhttp://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology\n\nOpen Targets\n\nLICENSE\n\nDatasets generated by the Open Targets Platform are freely available for download.\n\nhttps://platform-docs.opentargets.org/licence\n\nTENAMFETAMINE\n\nhttps://platform.opentargets.org/drug/CHEMBL6731\n\nChEMBL\n\nLICENSE\n\nAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).\n\nhttp://www.ebi.ac.uk/Information/termsofuse.html\n\nhttps://www.ebi.ac.uk/chembl/explore/compound/CHEMBL6731\n\nChEMBL Protein Target Tree\n\nhttps://www.ebi.ac.uk/chembl/g/#browse/targets\n\nClinicalTrials.gov\n\nLICENSE\n\n\n                    Context: \n                    This chunk provides key external identifiers and licensing information related to the chemical compound 3,4-methylenedioxyamphetamine (CHEBI:166520), including links to databases such as ChEBI, Open Targets, ChEMBL, and ClinicalTrials.gov. It situates the compound within chemical ontology and pharmacological resources, highlighting data accessibility and usage rights, and is relevant for researchers seeking comprehensive, linked chemical and biological data.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_78", "document_index": 31, "latency_s": 1.1501817999960622, "prompt_toks": 18041, "completion_toks": 82}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL6731\n\nChEMBL Protein Target Tree\n\nhttps://www.ebi.ac.uk/chembl/g/#browse/targets\n\nClinicalTrials.gov\n\nLICENSE\n\nThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.\n\nhttps://clinicaltrials.gov/ct2/about-site/terms-conditions#Use\n\nhttps://clinicaltrials.gov/\n\nComparative Toxicogenomics Database (CTD)\n\nLICENSE\n\nIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.\n\nhttp://ctdbase.org/about/legal.jsp\n\n3,4-Methylenedioxyamphetamine\n\nhttps://ctdbase.org/detail.go?type=chem&acc=D015104\n\nTherapeutic Target Database (TTD)\n\nMETHYLENEDIOXYAMPHETAMINE\n\n\n                    Context: \n                    This chunk provides key external links and licensing information related to the chemical METHYLENEDIOXYAMPHETAMINE, including connections to the ChEMBL Protein Target Tree, ClinicalTrials.gov, CTD, and TTD databases. It enhances the comprehensive chemical profile by adding authoritative references for scientific research, regulatory data, and therapeutic target information relevant to PubChem's overall drug and chemical data compilation.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_79", "document_index": 31, "latency_s": 1.6390236000006553, "prompt_toks": 18112, "completion_toks": 94}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    http://ctdbase.org/about/legal.jsp\n\n3,4-Methylenedioxyamphetamine\n\nhttps://ctdbase.org/detail.go?type=chem&acc=D015104\n\nTherapeutic Target Database (TTD)\n\nMETHYLENEDIOXYAMPHETAMINE\n\nhttps://idrblab.net/ttd/data/drug/details/D02TMK\n\nIUPAC Digitized pKa Dataset\n\nbenzene, 1-(2-amino)propyl-3,4-methylenedioxy-\n\nhttps://github.com/IUPAC/Dissociation-Constants\n\nEPA Chemical and Products Database (CPDat)\n\nLICENSE\n\nhttps://www.epa.gov/privacy/privacy-act-laws-policies-and-resources\n\nhttps://comptox.epa.gov/dashboard/DTXSID40859958#exposure\n\nEPA CPDat Classification\n\nhttps://www.epa.gov/chemical-research/chemical-and-products-database-cpdat\n\nNIST Mass Spectrometry Data Center\n\nLICENSE\n\nData covered by the Standard Reference Data Act of 1968 as amended.\n\nhttps://www.nist.gov/srd/public-law\n\n3,4-Methylenedioxyamphetamine\n\nhttp://www.nist.gov/srd/nist1a.cfm\n\nJapan Chemical Substance Dictionary (Nikkaji)\n\nhttp://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J1.191.661I\n\n\n                    Context: \n                    This chunk provides authoritative links and identifiers for 3,4-methylenedioxyamphetamine from various chemical and toxicological data sources, including the CTD, TTD, IUPAC, EPA, NIST, and Japan Nikkaji dictionaries. It offers legal, safety, and analytical reference URLs that complement the comprehensive chemical, toxicological, and regulatory information presented in the full PubChem profile, enhancing scientific research, safety assessment, and regulatory compliance efforts.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_80", "document_index": 31, "latency_s": 1.0399153000034858, "prompt_toks": 18114, "completion_toks": 74}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    3,4-Methylenedioxyamphetamine\n\nhttp://www.nist.gov/srd/nist1a.cfm\n\nJapan Chemical Substance Dictionary (Nikkaji)\n\nhttp://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J1.191.661I\n\nhttp://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J1.191.662G\n\nhttp://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J40.084J\n\nKEGG\n\nLICENSE\n\nAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license\n\nhttps://www.kegg.jp/kegg/legal.html\n\nhttps://www.kegg.jp/entry/D12715\n\nTarget-based classification of drugs\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08310.keg\n\nMassBank Europe\n\nLICENSE\n\nhttps://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt\n\nTenamfetamine\n\nhttps://massbank.eu/MassBank/Result.jsp?inchikey=NGBBVGZWCFBOGO-UHFFFAOYSA-N\n\nMassBank of North America (MoNA)\n\nLICENSE\n\nThe content of the MoNA database is licensed under CC BY 4.0.\n\nhttps://mona.fiehnlab.ucdavis.edu/documentation/license\n\nMDA\n\n\n                    Context: \n                    This chunk provides external resource links and identifiers for 3,4-methylenedioxyamphetamine and related substances, including references to NIST, Japan Nikkaji, KEGG, and mass spectral databases. It supplements the full chemical profile by highlighting authoritative databases and licensing information, essential for researchers seeking detailed analytical, regulatory, or classification data for this compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_81", "document_index": 31, "latency_s": 1.226018200002727, "prompt_toks": 18180, "completion_toks": 82}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    MassBank of North America (MoNA)\n\nLICENSE\n\nThe content of the MoNA database is licensed under CC BY 4.0.\n\nhttps://mona.fiehnlab.ucdavis.edu/documentation/license\n\nMDA\n\nhttps://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27NGBBVGZWCFBOGO-UHFFFAOYSA-N%27)\n\nSpectraBase\n\nMDA ##\n\nhttps://spectrabase.com/spectrum/77vxwDKC5DZ\n\n3,4-Methylenedioxyamphetamine\n\nhttps://spectrabase.com/spectrum/BtKJJRrOfmm\n\nalpha-methyl-3,4-(methylenedioxy)phenethylamine\n\nhttps://spectrabase.com/spectrum/IjcU9FNGDtQ\n\nalpha-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE\n\nhttps://spectrabase.com/spectrum/K4PGBxxgIv6\n\nalpha-methyl-3,4-methylenedioxyphenethylamine\n\nhttps://spectrabase.com/spectrum/HZ5oenHuCO1\n\n3,4-METHYLENEDIOXYAMPHETAMINE;MDA\n\nhttps://spectrabase.com/spectrum/J2knqlcHlx0\n\n3,4-Methylenedioxyamphetamine\n\nhttps://spectrabase.com/spectrum/DbzhoxDgcve\n\n3,4-Methylenedioxyamphetamine\n\nhttps://spectrabase.com/spectrum/Dn5a4JkEGj2\n\n\n                    Context: \n                    This snippet provides specific spectral reference data for 3,4-methylenedioxyamphetamine (MDA) from the MassBank of North America (MoNA) and SpectraBase databases, including license information and direct links to associated spectra. It complements the comprehensive chemical profile by detailing publicly available spectral identifiers and spectra sources, enhancing searchability for analytical and research purposes within the broader chemical information dataset.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_82", "document_index": 31, "latency_s": 1.1108748999977252, "prompt_toks": 18107, "completion_toks": 82}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://spectrabase.com/spectrum/J2knqlcHlx0\n\n3,4-Methylenedioxyamphetamine\n\nhttps://spectrabase.com/spectrum/DbzhoxDgcve\n\n3,4-Methylenedioxyamphetamine\n\nhttps://spectrabase.com/spectrum/Dn5a4JkEGj2\n\nMetabolomics Workbench\n\n3,4-Methylenedioxyamphetamine\n\nhttps://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=49636\n\nNCI Thesaurus (NCIt)\n\nLICENSE\n\nUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.\n\nhttps://www.cancer.gov/policies/copyright-reuse\n\nhttps://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C80152\n\nNCI Thesaurus\n\nhttps://ncit.nci.nih.gov\n\nNORMAN Suspect List Exchange\n\nLICENSE\n\nData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0\n\nhttps://creativecommons.org/licenses/by/4.0/\n\n(+/-)-3,4-(Methylenedioxy)amphetamine\n\nNORMAN Suspect List Exchange Classification\n\n\n                    Context: \n                    This excerpt provides spectral and database references for 3,4-methylenedioxyamphetamine, including links to SpectrumBase spectra, Metabolomics Workbench data, and classifications from NCI Thesaurus, NORMAN, and other sources. It enhances the overall document's detailed chemical and toxicological profile by integrating external spectral data, licensing information, and chemical classifications relevant for research and forensic analysis.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_83", "document_index": 31, "latency_s": 1.3478267999889795, "prompt_toks": 18083, "completion_toks": 108}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    LICENSE\n\nData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0\n\nhttps://creativecommons.org/licenses/by/4.0/\n\n(+/-)-3,4-(Methylenedioxy)amphetamine\n\nNORMAN Suspect List Exchange Classification\n\nhttps://www.norman-network.com/nds/SLE/\n\nPharos\n\nLICENSE\n\nData accessed from Pharos and TCRD is publicly available from the primary sources listed above. Please respect their individual licenses regarding proper use and redistribution.\n\nhttps://pharos.nih.gov/about\n\nmethylenedioxyamphetamine\n\nhttps://pharos.nih.gov/ligands/W94AR2N82Q8D\n\nSpringer Nature\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/341356369\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/341145469\n\nThieme Chemistry\n\nLICENSE\n\nThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.\n\nhttps://creativecommons.org/licenses/by-nc-nd/4.0/\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/376756245\n\nWikidata\n\nLICENSE\n\nCCZero\n\nhttps://creativecommons.org/publicdomain/zero/1.0/\n\n\n                    Context: \n                    This excerpt presents licensing and classification information for the chemical compound (+/-)-3,4-(Methylenedioxy)amphetamine, including its CC-BY 4.0 license, NORMAN Suspect List Exchange classification, and links to data sources such as Pharos, Springer Nature, Thieme Chemistry, and Wikidata. It is relevant for researchers seeking legal and data source details on this compound within the comprehensive PubChem compound database. The section ensures proper attribution, source references, and license terms for data reuse and integration.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_84", "document_index": 31, "latency_s": 1.0572755000030156, "prompt_toks": 18089, "completion_toks": 92}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://creativecommons.org/licenses/by-nc-nd/4.0/\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/376756245\n\nWikidata\n\nLICENSE\n\nCCZero\n\nhttps://creativecommons.org/publicdomain/zero/1.0/\n\n3,4-methylenedioxyamphetamine\n\nhttps://www.wikidata.org/wiki/Q223020\n\nWikipedia\n\n3,4-Methylenedioxyamphetamine\n\nhttps://en.wikipedia.org/wiki/3,4-Methylenedioxyamphetamine\n\nMedical Subject Headings (MeSH)\n\nLICENSE\n\nWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.\n\nhttps://www.nlm.nih.gov/copyright.html\n\n3,4-Methylenedioxyamphetamine\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68015104\n\nMeSH Tree\n\nhttp://www.nlm.nih.gov/mesh/meshhome.html\n\nAdrenergic Uptake Inhibitors\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68018759\n\nHallucinogens\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68006213\n\nSerotonin Agents\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68018490\n\n\n                    Context: \n                    This excerpt provides licensing and identifier information for 3,4-methylenedioxyamphetamine from sources like Wikidata, Wikipedia, and MeSH, including relevant URLs and license types (CCZero, CC BY-NC-ND 4.0). It is part of the comprehensive chemical data webpage, supporting searchability and proper attribution for scientific and regulatory reference. This section is essential for locating legal, metadata, and classification details related to the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Tenamfetamine | C10H13NO2 | CID 1614 - PubChem", "description": "Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1614", "drug": "MDA", "cid": 1614, "char_count": 61382, "word_count": 7520, "doc_id": "doc_31", "num_chunks": 86, "chunk_id": "31::chunk_85", "document_index": 31, "latency_s": 1.1257666000019526, "prompt_toks": 18052, "completion_toks": 104}, "content": "Drug: MDA | cid: 1614\nSource: pubchem | Source description: Tenamfetamine | C10H13NO2 | CID 1614 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Adrenergic Uptake Inhibitors\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68018759\n\nHallucinogens\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68006213\n\nSerotonin Agents\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68018490\n\nPubChem\n\nhttps://pubchem.ncbi.nlm.nih.gov\n\nGHS Classification (UNECE)\n\nGHS Classification\n\nhttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html\n\nEPA Substance Registry Services\n\nLICENSE\n\nhttps://www.epa.gov/privacy/privacy-act-laws-policies-and-resources\n\nEPA SRS List Classification\n\nhttps://maldi.nist.gov\n\nMolGenie\n\nLICENSE\n\nCC-BY 4.0\n\nhttps://creativecommons.org/licenses/by/4.0/\n\nMolGenie Organic Chemistry Ontology\n\nhttps://github.com/MolGenie/ontology/\n\nPATENTSCOPE (WIPO)\n\nSID 403541893\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/403541893\n\nNCBI\n\nhttps://www.ncbi.nlm.nih.gov/projects/linkout\n\n\n                    Context: \n                    This segment provides key classification, regulatory, and identifier information related to chemical substances such as adrenergic uptake inhibitors, hallucinogens, and serotonin agents. It includes links to authoritative databases like NCBI Mesh, PubChem, UNECE GHS, EPA SRS, and MolGenie, as well as patent identifiers (SID 403541893). This information is essential for researchers or regulatory professionals seeking detailed chemical, toxicological, and patent data on these compound classes within the comprehensive PubChem compound profile.\n                "}
